Term	Accession	Genes (tot)	Stat (non-dir.) p	p adj (non-dir.)	Significant..in.gene.set.	Non.significant..in.gene.set.	Significant..not.in.gene.set.	Non.significant..not.in.gene.set.	effect.size
R-HSA-109606	Intrinsic Pathway for Apoptosis	 40	0.57621764560007	1	19	21	3919	4282	0.994026155408837
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region 	 57	0.0137871857652609	0.190312953799443	36	21	3902	4282	1.3216968271364
R-HSA-109704	PI3K Cascade	 32	0.609290931330866	1	15	17	3923	4286	0.9809468638903
R-HSA-110056	MAPK3 (ERK1) activation	 10	0.137803517982411	0.566564079971367	7	3	3931	4300	1.46488065007618
R-HSA-110312	Translesion synthesis by REV1	 15	0.113632089157941	0.530161290572901	10	5	3928	4298	1.39512442864398
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	 35	0.529329695873636	0.991041791887285	17	18	3921	4285	1.01644779801204
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	 26	0.207170658079939	0.686311928936054	15	11	3923	4292	1.20731921709575
R-HSA-110320	Translesion Synthesis by POLH	 18	0.0318843572309661	0.284161595567599	13	5	3925	4298	1.51138479769765
R-HSA-110328	Recognition and association of DNA glycosylase with site containing an affected pyrimidine	  7	0.0491362727338201	0.334726440078746	6	1	3932	4302	1.79373140825655
R-HSA-110329	Cleavage of the damaged pyrimidine 	  7	0.0491362727338201	0.334726440078746	6	1	3932	4302	1.79373140825655
R-HSA-110357	Displacement of DNA glycosylase by APEX1	  8	0.0264284361188029	0.255651072055887	7	1	3931	4302	1.83110081259523
R-HSA-110362	POLB-Dependent Long Patch Base Excision Repair	  8	0.0264284361188029	0.255651072055887	7	1	3931	4302	1.83110081259523
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	 23	0.147121703269295	0.573853740440181	14	9	3924	4294	1.27380926093581
R-HSA-111367	SLBP independent Processing of Histone Pre-mRNAs	  9	0.886499944435254	1	3	6	3935	4297	0.697562214321991
R-HSA-111447	Activation of BAD and translocation to mitochondria 	 15	0.113632089157941	0.530161290572901	10	5	3928	4298	1.39512442864398
R-HSA-111448	Activation of NOXA and translocation to mitochondria	  5	0.78366872375152	1	2	3	3936	4300	0.837074657186389
R-HSA-111453	BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members	  8	0.587348598285987	1	4	4	3934	4299	1.04634332148299
R-HSA-111465	Apoptotic cleavage of cellular proteins	 32	0.609290931330866	1	15	17	3923	4286	0.9809468638903
R-HSA-111885	Opioid Signalling	 74	0.231423328373174	0.720590664097588	39	35	3899	4268	1.10290241994153
R-HSA-111931	PKA-mediated phosphorylation of CREB	 18	0.839440366169065	1	7	11	3931	4292	0.813822583375656
R-HSA-111933	Calmodulin induced events	 26	0.640506040097296	1	12	14	3926	4289	0.965855373676603
R-HSA-111996	Ca-dependent events	 28	0.629311627077588	1	13	15	3925	4288	0.97160451280563
R-HSA-111997	CaM pathway	 26	0.640506040097296	1	12	14	3926	4289	0.965855373676603
R-HSA-112040	G-protein mediated events	 43	0.733901089757673	1	19	24	3919	4279	0.924675493403569
R-HSA-112043	PLC beta mediated events	 42	0.786524216149685	1	18	24	3920	4279	0.896865704128274
R-HSA-112308	Presynaptic depolarization and calcium channel opening	 12	0.328659742153142	0.818236200316395	7	5	3931	4298	1.22073387506348
R-HSA-112310	Neurotransmitter release cycle	 46	0.000275092633575096	0.0220513146360007	34	12	3904	4291	1.5467683882792
R-HSA-112311	Neurotransmitter clearance	  9	0.97341621551606	1	2	7	3936	4296	0.465041476214661
R-HSA-112382	Formation of RNA Pol II elongation complex 	 49	0.07227946488213	0.419510014175883	29	20	3909	4283	1.23852882951047
R-HSA-112399	IRS-mediated signalling	 36	0.459533110942901	0.918433256168249	18	18	3920	4285	1.04634332148299
R-HSA-112409	RAF-independent MAPK1/3 activation	 22	0.100707670695172	0.49578463748403	14	8	3924	4295	1.33170968188744
R-HSA-112411	MAPK1 (ERK2) activation	  9	0.0698085957545361	0.416325844741537	7	2	3931	4301	1.62764516675131
R-HSA-112412	SOS-mediated signalling	  7	0.0491362727338201	0.334726440078746	6	1	3932	4302	1.79373140825655
R-HSA-113418	Formation of the Early Elongation Complex	 27	0.037540890234955	0.314866079369478	18	9	3920	4294	1.39512442864398
R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	 12	0.328659742153142	0.818236200316395	7	5	3931	4298	1.22073387506348
R-HSA-113507	E2F-enabled inhibition of pre-replication complex formation	  8	0.31592015436873	0.818236200316395	5	3	3933	4300	1.30792915185373
R-HSA-113510	E2F mediated regulation of DNA replication	 20	0.192001881713922	0.666494570255742	12	8	3926	4295	1.25561198577958
R-HSA-114452	Activation of BH3-only proteins	 30	0.474992990458817	0.940265796938258	15	15	3923	4288	1.04634332148299
R-HSA-114508	Effects of PIP2 hydrolysis	 24	0.336011657617902	0.818236200316395	13	11	3925	4292	1.13353859827324
R-HSA-114516	Disinhibition of SNARE formation	  5	0.160967868205754	0.608240564496221	4	1	3934	4302	1.67414931437278
R-HSA-114604	GPVI-mediated activation cascade	 48	0.993400847925401	1	15	33	3923	4270	0.653964575926866
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	 70	0.112487761594177	0.530161290572901	39	31	3899	4272	1.16592541536676
R-HSA-1169091	Activation of NF-kappaB in B cells	 57	0.192639701458943	0.667112665434191	31	26	3907	4277	1.13812782336746
R-HSA-1169092	Activation of RAS in B cells	  5	0.78366872375152	1	2	3	3936	4300	0.837074657186389
R-HSA-1169408	ISG15 antiviral mechanism	 64	0.606405507712536	1	30	34	3908	4269	0.9809468638903
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	 64	0.606405507712536	1	30	34	3908	4269	0.9809468638903
R-HSA-1170546	Prolactin receptor signaling	 12	0.15371300757141	0.596357149695497	8	4	3930	4299	1.39512442864398
R-HSA-1181150	Signaling by NODAL	 17	0.61724514479494	1	8	9	3930	4294	0.984793714336928
R-HSA-1187000	Fertilization	 11	0.955170261510425	1	3	8	3935	4295	0.570732720808902
R-HSA-1221632	Meiotic synapsis	 43	0.8927801292953	1	17	26	3921	4277	0.827341230940036
R-HSA-1222556	ROS, RNS production in phagocytes	 27	0.0823170472148334	0.455885631712684	17	10	3921	4293	1.31761751594154
R-HSA-1226099	Signaling by FGFR in disease	 55	0.191675635384801	0.666494570255742	30	25	3908	4278	1.1414654416178
R-HSA-1227986	Signaling by ERBB2	 45	0.0361752642598603	0.308766520241513	28	17	3910	4286	1.30211613340105
R-HSA-1234158	Regulation of gene expression by Hypoxia-inducible Factor	 10	0.928057578421412	1	3	7	3935	4296	0.627805992889792
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	 64	0.606405507712536	1	30	34	3908	4269	0.9809468638903
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	 56	0.420628249471698	0.918433256168249	28	28	3910	4275	1.04634332148299
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	 17	0.0156736968712207	0.197568507635796	13	4	3925	4299	1.60028978579751
R-HSA-1236394	Signaling by ERBB4	 39	0.0133905585434929	0.190312953799443	26	13	3912	4290	1.39512442864398
R-HSA-1236973	Cross-presentation of particulate exogenous antigens (phagosomes)	  7	0.989443342380119	1	1	6	3937	4297	0.298955234709425
R-HSA-1236974	ER-Phagosome pathway	 69	0.799394318233717	1	30	39	3908	4264	0.909863757811292
R-HSA-1236975	Antigen processing-Cross presentation	 81	0.917760321818745	1	33	48	3905	4255	0.852576039726878
R-HSA-1236977	Endosomal/Vacuolar pathway	  8	0.954101488609214	1	2	6	3936	4297	0.523171660741493
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	 39	0.641463892296054	1	18	21	3920	4282	0.965855373676603
R-HSA-1237044	Erythrocytes take up carbon dioxide and release oxygen	  9	0.886499944435254	1	3	6	3935	4297	0.697562214321991
R-HSA-1237112	Methionine salvage pathway	  5	0.458521658108405	0.918433256168249	3	2	3935	4301	1.25561198577958
R-HSA-1247673	Erythrocytes take up oxygen and release carbon dioxide	  5	1	1	0	5	3938	4298	0
R-HSA-1250196	SHC1 events in ERBB2 signaling	 19	0.132817548245669	0.566564079971367	12	7	3926	4296	1.3216968271364
R-HSA-1250342	PI3K events in ERBB4 signaling	  8	0.31592015436873	0.818236200316395	5	3	3933	4300	1.30792915185373
R-HSA-1250347	SHC1 events in ERBB4 signaling	 12	0.15371300757141	0.596357149695497	8	4	3930	4299	1.39512442864398
R-HSA-1251985	Nuclear signaling by ERBB4	 23	0.0708700783260921	0.416325844741537	15	8	3923	4295	1.36479563671694
R-HSA-1253288	Downregulation of ERBB4 signaling	  7	0.451634376327358	0.918433256168249	4	3	3934	4300	1.1958209388377
R-HSA-1266695	Interleukin-7 signaling	 30	0.474992990458817	0.940265796938258	15	15	3923	4288	1.04634332148299
R-HSA-1268020	Mitochondrial protein import	 51	0.00206947364353207	0.0637901629168669	35	16	3903	4287	1.43615750007469
R-HSA-1295596	Spry regulation of FGF signaling	 15	0.0413499874769008	0.32057602598237	11	4	3927	4299	1.53463687150838
R-HSA-1296041	Activation of G protein gated Potassium channels	 21	0.140467860660899	0.566564079971367	13	8	3925	4295	1.29547268374084
R-HSA-1296052	Ca2+ activated K+ channels	  8	0.954101488609214	1	2	6	3936	4297	0.523171660741493
R-HSA-1296059	G protein gated Potassium channels	 21	0.140467860660899	0.566564079971367	13	8	3925	4295	1.29547268374084
R-HSA-1296065	Inwardly rectifying K+ channels	 26	0.335682325220151	0.818236200316395	14	12	3924	4291	1.12683126928937
R-HSA-1296071	Potassium Channels	 84	0.928020806331335	1	34	50	3904	4253	0.847039831676703
R-HSA-1296072	Voltage gated Potassium channels	 36	0.892689522807154	1	14	22	3924	4281	0.813822583375656
R-HSA-1296346	Tandem pore domain potassium channels	 10	0.984755874789722	1	2	8	3936	4295	0.418537328593195
R-HSA-1306955	GRB7 events in ERBB2 signaling	  5	0.160967868205754	0.608240564496221	4	1	3934	4302	1.67414931437278
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	 12	0.0537310911895786	0.355999147562002	9	3	3929	4300	1.56951498222448
R-HSA-1362277	Transcription of E2F targets under negative control by DREAM complex	 16	0.715356771155285	1	7	9	3931	4294	0.915550406297613
R-HSA-1362300	Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1	 15	0.805145315275593	1	6	9	3932	4294	0.837074657186389
R-HSA-1362409	Mitochondrial iron-sulfur cluster biogenesis	 12	0.328659742153142	0.818236200316395	7	5	3931	4298	1.22073387506348
R-HSA-1368071	NR1D1 (REV-ERBA) represses gene expression	  7	0.73561681688831	1	3	4	3935	4299	0.896865704128274
R-HSA-1368082	RORA activates gene expression	 26	0.113176290538803	0.530161290572901	16	10	3922	4293	1.28780716490214
R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	 44	0.327339225467072	0.818236200316395	23	21	3915	4282	1.09390438155039
R-HSA-1369062	ABC transporters in lipid homeostasis	 15	0.430676252621717	0.918433256168249	8	7	3930	4296	1.11609954291519
R-HSA-139853	Elevation of cytosolic Ca2+ levels	 13	0.828863131149436	1	5	8	3933	4295	0.804879478063836
R-HSA-139915	Activation of PUMA and translocation to mitochondria	  9	0.97341621551606	1	2	7	3936	4296	0.465041476214661
R-HSA-140342	Apoptosis induced DNA fragmentation	 12	0.903289390204616	1	4	8	3934	4295	0.697562214321991
R-HSA-140534	Ligand-dependent caspase activation	 15	0.994034112436162	1	3	12	3935	4291	0.418537328593194
R-HSA-140837	Intrinsic Pathway of Fibrin Clot Formation	 16	0.944551976433802	1	5	11	3933	4292	0.653964575926866
R-HSA-140875	Common Pathway of Fibrin Clot Formation	 18	0.993629190070664	1	4	14	3934	4289	0.465041476214661
R-HSA-140877	Formation of Fibrin Clot (Clotting Cascade)	 30	0.99474450319479	1	8	22	3930	4281	0.558049771457593
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	 16	0.176576507876053	0.642136623880082	10	6	3928	4297	1.30792915185373
R-HSA-141424	Amplification of signal from the kinetochores	 73	0.441707198562105	0.918433256168249	36	37	3902	4266	1.03200985132569
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	 16	0.176576507876053	0.642136623880082	10	6	3928	4297	1.30792915185373
R-HSA-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	 73	0.441707198562105	0.918433256168249	36	37	3902	4266	1.03200985132569
R-HSA-1433557	Signaling by SCF-KIT	 40	0.694847185047313	1	18	22	3920	4281	0.941708989334688
R-HSA-1433559	Regulation of KIT signaling	 15	0.805145315275593	1	6	9	3932	4294	0.837074657186389
R-HSA-1433617	Regulation of signaling by NODAL	  9	0.445617652045213	0.918433256168249	5	4	3933	4299	1.16260369053665
R-HSA-1442490	Collagen degradation	 52	0.962346891200218	1	19	33	3919	4270	0.764635504160644
R-HSA-1445148	Translocation of GLUT4 to the plasma membrane	 66	0.00324067083565077	0.083968096116594	43	23	3895	4280	1.36341705526571
R-HSA-1461957	Beta defensins	  5	1	1	0	5	3938	4298	0
R-HSA-1461973	Defensins	  9	0.997126674022736	1	1	8	3937	4295	0.23252073810733
R-HSA-1474151	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	  9	0.700733355278605	1	4	5	3934	4298	0.930082952429321
R-HSA-1474165	Reproduction	 70	0.924123419525983	1	28	42	3910	4261	0.837074657186389
R-HSA-1474290	Collagen formation	 77	0.887828266893666	1	32	45	3906	4258	0.869687955518326
R-HSA-1475029	Reversible hydration of carbon dioxide	 10	0.928057578421412	1	3	7	3935	4296	0.627805992889792
R-HSA-1480926	O2/CO2 exchange in erythrocytes	  9	0.886499944435254	1	3	6	3935	4297	0.697562214321991
R-HSA-1482788	Acyl chain remodelling of PC	 20	0.821370442274037	1	8	12	3930	4291	0.837074657186389
R-HSA-1482798	Acyl chain remodeling of CL	  6	0.303133259568907	0.818236200316395	4	2	3934	4301	1.39512442864398
R-HSA-1482801	Acyl chain remodelling of PS	 16	0.944551976433802	1	5	11	3933	4292	0.653964575926866
R-HSA-1482839	Acyl chain remodelling of PE	 23	0.851178522224523	1	9	14	3929	4289	0.818877382030163
R-HSA-1482922	Acyl chain remodelling of PI	 13	0.828863131149436	1	5	8	3933	4295	0.804879478063836
R-HSA-1482925	Acyl chain remodelling of PG	 14	0.880263602988144	1	5	9	3933	4294	0.747388086773562
R-HSA-1483115	Hydrolysis of LPC	  6	0.613910056647902	1	3	3	3935	4300	1.04634332148299
R-HSA-1483148	Synthesis of PG	  8	0.31592015436873	0.818236200316395	5	3	3933	4300	1.30792915185373
R-HSA-1483166	Synthesis of PA	 31	0.271541935044563	0.772928726676344	17	14	3921	4289	1.14760235259424
R-HSA-1483191	Synthesis of PC	 24	0.493658163779772	0.959013532174145	12	12	3926	4291	1.04634332148299
R-HSA-1483213	Synthesis of PE	 11	0.440211273532975	0.918433256168249	6	5	3932	4298	1.1414654416178
R-HSA-1483226	Synthesis of PI	  5	0.78366872375152	1	2	3	3936	4300	0.837074657186389
R-HSA-1483249	Inositol phosphate metabolism	 45	0.274866452767053	0.772928726676344	24	21	3914	4282	1.11609954291519
R-HSA-1483255	PI Metabolism	 77	0.197800665942672	0.669358877079889	41	36	3897	4267	1.11428769300786
R-HSA-1489509	DAG and IP3 signaling	 32	0.469548163622403	0.933307377282338	16	16	3922	4287	1.04634332148299
R-HSA-1500620	Meiosis	 59	0.832938588669898	1	25	34	3913	4269	0.886731628375412
R-HSA-1502540	Signaling by Activin	 12	0.328659742153142	0.818236200316395	7	5	3931	4298	1.22073387506348
R-HSA-1538133	G0 and Early G1	 24	0.888416350583373	1	9	15	3929	4288	0.78475749111224
R-HSA-156580	Phase II - Conjugation of compounds	 65	0.737858923400471	1	29	36	3909	4267	0.933660194554049
R-HSA-156581	Methylation	 12	0.760692490142898	1	5	7	3933	4296	0.871952767902489
R-HSA-156584	Cytosolic sulfonation of small molecules	 17	0.784034909607526	1	7	10	3931	4293	0.861694500044812
R-HSA-156588	Glucuronidation	  6	0.613910056647902	1	3	3	3935	4300	1.04634332148299
R-HSA-156590	Glutathione conjugation	 26	0.640506040097296	1	12	14	3926	4289	0.965855373676603
R-HSA-1566948	Elastic fibre formation	 38	0.999963488415256	1	7	31	3931	4272	0.385494907914784
R-HSA-1566977	Fibronectin matrix formation	  5	0.961231891425561	1	1	4	3937	4299	0.418537328593195
R-HSA-156711	Polo-like kinase mediated events	 11	0.991330455518455	1	2	9	3936	4294	0.380488480539268
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	 59	0.571138490375013	1	28	31	3910	4272	0.993139423780461
R-HSA-156842	Eukaryotic Translation Elongation	 45	0.61705619945913	1	21	24	3917	4279	0.976587100050787
R-HSA-156902	Peptide chain elongation	 43	0.624798444222717	1	20	23	3918	4280	0.973342624635336
R-HSA-157579	Telomere Maintenance	 50	0.982956109146268	1	17	33	3921	4270	0.711513458608431
R-HSA-157858	Gap junction trafficking and regulation	 39	0.516487312333312	0.97535482363707	19	20	3919	4283	1.01951400554753
R-HSA-15869	Metabolism of nucleotides	 88	0.77666475213484	1	39	49	3899	4254	0.927440671314465
R-HSA-1592230	Mitochondrial biogenesis	 85	5.6836975606074e-06	0.00206176129011033	61	24	3877	4279	1.50181041436382
R-HSA-159227	Transport of the SLBP independent Mature mRNA	 32	0.216715720839776	0.698787802085589	18	14	3920	4289	1.17713623666836
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	 33	0.17016007900559	0.62760402454511	19	14	3919	4289	1.20488018837435
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	 38	0.138375835764659	0.566564079971367	22	16	3916	4287	1.21155542487504
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	 39	0.107191135175319	0.518447790464625	23	16	3915	4287	1.23414853303121
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	 63	0.0304725936626151	0.278086373612921	38	25	3900	4278	1.26225543543979
R-HSA-1592389	Activation of Matrix Metalloproteinases	 28	0.999965115681552	1	4	24	3934	4279	0.298955234709425
R-HSA-159418	Recycling of bile acids and salts	 11	0.440211273532975	0.918433256168249	6	5	3932	4298	1.1414654416178
R-HSA-159740	Gamma-carboxylation of protein precursors	  8	0.954101488609214	1	2	6	3936	4297	0.523171660741493
R-HSA-159763	Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus	  7	0.989443342380119	1	1	6	3937	4297	0.298955234709425
R-HSA-159782	Removal of aminoterminal propeptides from gamma-carboxylated proteins	  8	0.994492178633106	1	1	7	3937	4296	0.261585830370747
R-HSA-159854	Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	  9	0.97341621551606	1	2	7	3936	4296	0.465041476214661
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	 24	0.888416350583373	1	9	15	3929	4288	0.78475749111224
R-HSA-1606341	IRF3 mediated activation of type 1 IFN	  5	0.78366872375152	1	2	3	3936	4300	0.837074657186389
R-HSA-1614517	Sulfide oxidation to sulfate	  5	0.961231891425561	1	1	4	3937	4299	0.418537328593195
R-HSA-1614558	Degradation of cysteine and homocysteine	  9	0.700733355278605	1	4	5	3934	4298	0.930082952429321
R-HSA-1614635	Sulfur amino acid metabolism	 19	0.422334246450265	0.918433256168249	10	9	3928	4294	1.10141402261367
R-HSA-162588	Budding and maturation of HIV virion	 24	0.336011657617902	0.818236200316395	13	11	3925	4292	1.13353859827324
R-HSA-162592	Integration of provirus	  9	0.445617652045213	0.918433256168249	5	4	3933	4299	1.16260369053665
R-HSA-162594	Early Phase of HIV Life Cycle	 14	0.538655708122675	0.996925296538267	7	7	3931	4296	1.04634332148299
R-HSA-162658	Golgi Cisternae Pericentriolar Stack Reorganization	 12	0.760692490142898	1	5	7	3933	4296	0.871952767902489
R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI)	 17	0.426382730531353	0.918433256168249	9	8	3929	4295	1.10789292862904
R-HSA-162791	Attachment of GPI anchor to uPAR	  7	0.0491362727338201	0.334726440078746	6	1	3932	4302	1.79373140825655
R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins	 76	0.86692390371611	1	32	44	3906	4259	0.881131218090936
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	 94	1.07742071248557e-07	0.000156333745381656	70	24	3868	4279	1.55838367029381
R-HSA-163210	Formation of ATP by chemiosmotic coupling	 14	0.00401894675255738	0.0940563183542057	12	2	3926	4301	1.79373140825655
R-HSA-1632852	Macroautophagy	 63	0.00854501430221403	0.151205070152592	40	23	3898	4280	1.32868993204189
R-HSA-163358	PKA-mediated phosphorylation of key metabolic factors	  5	0.78366872375152	1	2	3	3936	4300	0.837074657186389
R-HSA-163359	Glucagon signaling in metabolic regulation	 28	0.629311627077588	1	13	15	3925	4288	0.97160451280563
R-HSA-163560	Triglyceride catabolism	 21	0.993640442773991	1	5	16	3933	4287	0.498258724515708
R-HSA-163615	PKA activation	 17	0.899918550187916	1	6	11	3932	4292	0.738595285752696
R-HSA-163680	AMPK inhibits chREBP transcriptional activation activity	  7	0.451634376327358	0.918433256168249	4	3	3934	4300	1.1958209388377
R-HSA-163685	Integration of energy metabolism	100	0.0601393577077572	0.38783203570647	56	44	3882	4259	1.17190452006094
R-HSA-163765	ChREBP activates metabolic gene expression	  7	0.451634376327358	0.918433256168249	4	3	3934	4300	1.1958209388377
R-HSA-163767	PP2A-mediated dephosphorylation of key metabolic factors	  7	0.191757422000069	0.666494570255742	5	2	3933	4301	1.49477617354712
R-HSA-1638074	Keratan sulfate/keratin metabolism	 31	0.973555333276581	1	10	21	3928	4282	0.675060207408378
R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	 51	0.789877459344044	1	22	29	3916	4274	0.902727571475518
R-HSA-163841	Gamma carboxylation, hypusine formation and arylsulfatase activation	 35	0.963001102114729	1	12	23	3926	4280	0.717492563302619
R-HSA-1643713	Signaling by EGFR in Cancer	 17	0.0156736968712207	0.197568507635796	13	4	3925	4299	1.60028978579751
R-HSA-164378	PKA activation in glucagon signalling	 17	0.899918550187916	1	6	11	3932	4292	0.738595285752696
R-HSA-164843	2-LTR circle formation	  7	0.73561681688831	1	3	4	3935	4299	0.896865704128274
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	 18	0.33517537546619	0.818236200316395	10	8	3928	4295	1.16260369053665
R-HSA-164940	Nef mediated downregulation of MHC class I complex cell surface expression	  8	0.587348598285987	1	4	4	3934	4299	1.04634332148299
R-HSA-164944	Nef and signal transduction	  7	0.451634376327358	0.918433256168249	4	3	3934	4300	1.1958209388377
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	 24	0.202901000970507	0.678362563152547	14	10	3924	4293	1.22073387506348
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	 33	0.0962569752558463	0.488352696140675	20	13	3918	4290	1.26829493513089
R-HSA-1650814	Collagen biosynthesis and modifying enzymes	 57	0.677350969703329	1	26	31	3912	4272	0.954558819598514
R-HSA-165159	mTOR signalling	 37	0.0271371408655009	0.259052574972644	24	13	3914	4290	1.35741836300496
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	 53	9.80702503444044e-06	0.00237166555416218	41	12	3897	4291	1.61887079927556
R-HSA-1660499	Synthesis of PIPs at the plasma membrane	 50	0.543509134552689	1	24	26	3914	4277	1.00448958862367
R-HSA-1660514	Synthesis of PIPs at the Golgi membrane	 14	0.33187102925713	0.818236200316395	8	6	3930	4297	1.1958209388377
R-HSA-1660516	Synthesis of PIPs at the early endosome membrane	 16	0.176576507876053	0.642136623880082	10	6	3928	4297	1.30792915185373
R-HSA-1660517	Synthesis of PIPs at the late endosome membrane	 11	0.087058396650189	0.464288021493932	8	3	3930	4300	1.52195392215707
R-HSA-166058	MyD88:Mal cascade initiated on plasma membrane	 89	0.417434932426507	0.918433256168249	44	45	3894	4258	1.03458665494947
R-HSA-1660661	Sphingolipid de novo biosynthesis	 41	0.632921437166122	1	19	22	3919	4281	0.969781615033012
R-HSA-1660662	Glycosphingolipid metabolism	 39	0.641463892296054	1	18	21	3920	4282	0.965855373676603
R-HSA-166166	MyD88-independent TLR4 cascade 	 93	0.145431670000797	0.573853740440181	50	43	3888	4260	1.12510034568063
R-HSA-166208	mTORC1-mediated signalling	 21	0.260713909784619	0.772928726676344	12	9	3926	4294	1.1958209388377
R-HSA-1663150	The activation of arylsulfatases	 11	0.991330455518455	1	2	9	3936	4294	0.380488480539268
R-HSA-166658	Complement cascade	 46	0.999999901951414	1	6	40	3932	4263	0.272959127343388
R-HSA-166662	Lectin pathway of complement activation	  5	1	1	0	5	3938	4298	0
R-HSA-166663	Initial triggering of complement	 25	1	1	0	25	3938	4278	0
R-HSA-166665	Terminal pathway of complement	  6	0.979768658250007	1	1	5	3937	4298	0.348781107160995
R-HSA-166786	Creation of C4 and C2 activators	 19	1	1	0	19	3938	4284	0
R-HSA-167044	Signalling to RAS	 20	0.915906277694761	1	7	13	3931	4290	0.73244032503809
R-HSA-167152	Formation of HIV elongation complex in the absence of HIV Tat	 37	0.0271371408655009	0.259052574972644	24	13	3914	4290	1.35741836300496
R-HSA-167158	Formation of the HIV-1 Early Elongation Complex	 27	0.037540890234955	0.314866079369478	18	9	3920	4294	1.39512442864398
R-HSA-167160	RNA Pol II CTD phosphorylation and interaction with CE during HIV infection	 22	0.015794587791697	0.197568507635796	16	6	3922	4297	1.52195392215707
R-HSA-167161	HIV Transcription Initiation	 40	0.141348171571078	0.566564079971367	23	17	3915	4286	1.20329481970543
R-HSA-167162	RNA Polymerase II HIV Promoter Escape	 40	0.141348171571078	0.566564079971367	23	17	3915	4286	1.20329481970543
R-HSA-167169	HIV Transcription Elongation	 35	0.0247335413389316	0.252484197298917	23	12	3915	4291	1.37519407966335
R-HSA-167172	Transcription of the HIV genome	 60	0.0652456887169451	0.396062653800984	35	25	3903	4278	1.22073387506348
R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat	 35	0.0247335413389316	0.252484197298917	23	12	3915	4291	1.37519407966335
R-HSA-167238	Pausing and recovery of Tat-mediated HIV elongation	 26	0.113176290538803	0.530161290572901	16	10	3922	4293	1.28780716490214
R-HSA-167242	Abortive elongation of HIV-1 transcript in the absence of Tat	 20	0.192001881713922	0.666494570255742	12	8	3926	4295	1.25561198577958
R-HSA-167243	Tat-mediated HIV elongation arrest and recovery	 26	0.113176290538803	0.530161290572901	16	10	3922	4293	1.28780716490214
R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript	 35	0.0247335413389316	0.252484197298917	23	12	3915	4291	1.37519407966335
R-HSA-167287	HIV elongation arrest and recovery	 28	0.11848377710558	0.535576201184411	17	11	3921	4292	1.27055974751505
R-HSA-167290	Pausing and recovery of HIV elongation	 28	0.11848377710558	0.535576201184411	17	11	3921	4292	1.27055974751505
R-HSA-167590	Nef Mediated CD4 Down-regulation	  9	0.212162156227543	0.693349749293164	6	3	3932	4300	1.39512442864398
R-HSA-1679131	Trafficking and processing of endosomal TLR	 12	0.903289390204616	1	4	8	3934	4295	0.697562214321991
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	 91	0.144960677614454	0.573853740440181	49	42	3889	4261	1.12683126928937
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	 80	0.117906338261745	0.535576201184411	44	36	3894	4267	1.15097765363129
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	 92	0.170440657408389	0.62760402454511	49	43	3889	4260	1.11458310331883
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	 80	0.117906338261745	0.535576201184411	44	36	3894	4267	1.15097765363129
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	 90	0.457769894817878	0.918433256168249	44	46	3894	4257	1.02309124767225
R-HSA-168180	TRAF6 Mediated Induction of proinflammatory cytokines	 77	0.140422788849935	0.566564079971367	42	35	3896	4268	1.1414654416178
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	 87	0.198362727184254	0.669358877079889	46	41	3892	4262	1.10647799513143
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	 89	0.417434932426507	0.918433256168249	44	45	3894	4258	1.03458665494947
R-HSA-168253	Host Interactions with Influenza Factors	 39	0.178732507115569	0.648352169561728	22	17	3916	4286	1.18048990116029
R-HSA-168255	Influenza Life Cycle	 94	0.037351460903896	0.314866079369478	54	40	3884	4263	1.20218168851237
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	 30	0.0634070647939037	0.396062653800984	19	11	3919	4292	1.32536820721178
R-HSA-168273	Influenza Viral RNA Transcription and Replication	 85	0.0996201675717989	0.49578463748403	47	38	3891	4265	1.15713261434589
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	 31	0.166593644389095	0.618228588257232	18	13	3920	4290	1.21510837333508
R-HSA-168276	 NS1 Mediated Effects on Host Pathways	 37	0.103829666952241	0.503869052667898	22	15	3916	4288	1.24430016608788
R-HSA-168325	Viral Messenger RNA Synthesis	 40	0.043518353786832	0.329572300043275	25	15	3913	4288	1.30792915185373
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	 30	0.123274361230653	0.551744358397404	18	12	3920	4291	1.25561198577958
R-HSA-168638	NOD1/2 Signaling Pathway	 32	0.469548163622403	0.933307377282338	16	16	3922	4287	1.04634332148299
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	 48	0.228704630085272	0.719761606298485	26	22	3912	4281	1.13353859827324
R-HSA-168799	Neurotoxicity of clostridium toxins	 10	0.00737565229295146	0.142694286360968	9	1	3929	4302	1.88341797866938
R-HSA-168927	TICAM1, RIP1-mediated IKK complex recruitment 	 16	0.527427538082664	0.988756276173056	8	8	3930	4295	1.04634332148299
R-HSA-168928	DDX58/IFIH1-mediated induction of interferon-alpha/beta	 66	0.692342771999904	1	30	36	3908	4267	0.951221201348169
R-HSA-169893	Prolonged ERK activation events	 11	0.440211273532975	0.918433256168249	6	5	3932	4298	1.1414654416178
R-HSA-169911	Regulation of Apoptosis	 44	0.327339225467072	0.818236200316395	23	21	3915	4282	1.09390438155039
R-HSA-170660	Adenylate cyclase activating pathway	 10	0.984755874789722	1	2	8	3936	4295	0.418537328593195
R-HSA-170670	Adenylate cyclase inhibitory pathway	 13	0.983292732593995	1	3	10	3935	4293	0.482927686838301
R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	 30	0.213989646620597	0.694628584444041	17	13	3921	4290	1.18585576434738
R-HSA-170834	Signaling by TGF-beta Receptor Complex	 69	0.35533414693411	0.857886601000656	35	34	3903	4269	1.06150771744651
R-HSA-170968	Frs2-mediated activation	  9	0.700733355278605	1	4	5	3934	4298	0.930082952429321
R-HSA-170984	ARMS-mediated activation	  7	0.73561681688831	1	3	4	3935	4299	0.896865704128274
R-HSA-171007	p38MAPK events	 13	0.828863131149436	1	5	8	3933	4295	0.804879478063836
R-HSA-171306	Packaging Of Telomere Ends	 23	0.997508368710998	1	5	18	3933	4285	0.454931878905646
R-HSA-171319	Telomere Extension By Telomerase	  6	0.86854805730333	1	2	4	3936	4299	0.697562214321991
R-HSA-173623	Classical antibody-mediated complement activation	 14	1	1	0	14	3938	4289	0
R-HSA-173736	Alternative complement activation	  5	1	1	0	5	3938	4298	0
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	 19	0.256732391580523	0.772860373824353	11	8	3927	4295	1.21155542487504
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	 53	0.19059852157244	0.666494570255742	29	24	3909	4279	1.14505495558515
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	 45	0.38219712419891	0.913621132145993	23	22	3915	4281	1.06959539529372
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	 72	0.397165941731567	0.918433256168249	36	36	3902	4267	1.04634332148299
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	 55	0.273778762709046	0.772928726676344	29	26	3909	4277	1.10341659356388
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	 60	0.317277465099618	0.818236200316395	31	29	3907	4274	1.08122143219909
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	 59	0.272919995885891	0.772928726676344	31	28	3907	4275	1.09954721918551
R-HSA-174362	Transport and synthesis of PAPS	  5	0.458521658108405	0.918433256168249	3	2	3935	4301	1.25561198577958
R-HSA-174403	Glutathione synthesis and recycling	 11	0.440211273532975	0.918433256168249	6	5	3932	4298	1.1414654416178
R-HSA-174411	Polymerase switching on the C-strand of the telomere	 11	0.67363845463036	1	5	6	3933	4297	0.951221201348169
R-HSA-174414	Processive synthesis on the C-strand of the telomere	  9	0.445617652045213	0.918433256168249	5	4	3933	4299	1.16260369053665
R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	 21	0.590936188394649	1	10	11	3928	4292	0.996517449031415
R-HSA-174430	Telomere C-strand synthesis initiation	  7	1	1	0	7	3938	4296	0
R-HSA-174437	Removal of the Flap Intermediate from the C-strand	  8	0.587348598285987	1	4	4	3934	4299	1.04634332148299
R-HSA-174490	Membrane binding and targetting of GAG proteins	 13	0.651619464532439	1	6	7	3932	4296	0.965855373676603
R-HSA-174495	Synthesis And Processing Of GAG, GAGPOL Polyproteins	 13	0.651619464532439	1	6	7	3932	4296	0.965855373676603
R-HSA-174577	Activation of C3 and C5	  5	1	1	0	5	3938	4298	0
R-HSA-174824	Plasma lipoprotein assembly, remodeling, and clearance	 57	0.766396276111676	1	25	32	3913	4271	0.917845018844725
R-HSA-175474	Assembly Of The HIV Virion	 15	0.633137731686013	1	7	8	3931	4295	0.976587100050787
R-HSA-176033	Interactions of Vpr with host cellular proteins	 35	0.100194011152409	0.49578463748403	21	14	3917	4289	1.25561198577958
R-HSA-176187	Activation of ATR in response to replication stress	 27	0.0148260799676437	0.197568507635796	19	8	3919	4295	1.47263134134643
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	 16	0.0758654379270744	0.433388781229074	11	5	3927	4298	1.43872206703911
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	 66	0.313396803841339	0.818236200316395	34	32	3904	4271	1.07805069486126
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	 62	0.411264906359635	0.918433256168249	31	31	3907	4272	1.04634332148299
R-HSA-176412	Phosphorylation of the APC/C	 16	0.33392496716077	0.818236200316395	9	7	3929	4296	1.17713623666836
R-HSA-176417	Phosphorylation of Emi1	  5	0.961231891425561	1	1	4	3937	4299	0.418537328593195
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	 63	0.459475819569822	0.918433256168249	31	32	3907	4271	1.02973469733246
R-HSA-176974	Unwinding of DNA	 11	0.855757090184043	1	4	7	3934	4296	0.760976961078535
R-HSA-177243	Interactions of Rev with host cellular proteins	 35	0.100194011152409	0.49578463748403	21	14	3917	4289	1.25561198577958
R-HSA-177504	Retrograde neurotrophin signalling	 13	0.0325091832282712	0.284161595567599	10	3	3928	4300	1.60975895612767
R-HSA-177929	Signaling by EGFR	 41	0.0317812138165731	0.284161595567599	26	15	3912	4288	1.32706957846623
R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	 48	0.840370324834128	1	20	28	3918	4275	0.871952767902489
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	 20	0.192001881713922	0.666494570255742	12	8	3926	4295	1.25561198577958
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	 60	0.317277465099618	0.818236200316395	31	29	3907	4274	1.08122143219909
R-HSA-179812	GRB2 events in EGFR signaling	  6	0.0898851725241767	0.472548497581813	5	1	3933	4302	1.74390553580498
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	 65	0.455722544744683	0.918433256168249	32	33	3906	4270	1.03024573192171
R-HSA-180024	DARPP-32 events	 24	0.0490245166606896	0.334726440078746	16	8	3922	4295	1.39512442864398
R-HSA-180292	GAB1 signalosome	 10	0.567535190495185	1	5	5	3933	4298	1.04634332148299
R-HSA-180336	SHC1 events in EGFR signaling	  7	0.191757422000069	0.666494570255742	5	2	3933	4301	1.49477617354712
R-HSA-180534	Vpu mediated degradation of CD4	 43	0.504918088750334	0.970379002353292	21	22	3917	4281	1.0220097558671
R-HSA-180585	Vif-mediated degradation of APOBEC3G	 45	0.38219712419891	0.913621132145993	23	22	3915	4281	1.06959539529372
R-HSA-180689	APOBEC3G mediated resistance to HIV-1 infection	  5	0.78366872375152	1	2	3	3936	4300	0.837074657186389
R-HSA-180746	Nuclear import of Rev protein	 32	0.216715720839776	0.698787802085589	18	14	3920	4289	1.17713623666836
R-HSA-180786	Extension of Telomeres	 27	0.70462801258257	1	12	15	3926	4288	0.930082952429321
R-HSA-180910	Vpr-mediated nuclear import of PICs	 32	0.127609807149677	0.562801915423043	19	13	3919	4290	1.24253269426105
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	 20	0.915906277694761	1	7	13	3931	4290	0.73244032503809
R-HSA-181429	Serotonin Neurotransmitter Release Cycle	 16	0.000134942675695632	0.0139858444595973	15	1	3923	4302	1.9618937277806
R-HSA-181430	Norepinephrine Neurotransmitter Release Cycle	 18	0.00943882750208787	0.157422283971603	14	4	3924	4299	1.62764516675131
R-HSA-181431	Acetylcholine binding and downstream events	  8	1	1	0	8	3938	4295	0
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	 90	0.457769894817878	0.918433256168249	44	46	3894	4257	1.02309124767225
R-HSA-182218	Nef Mediated CD8 Down-regulation	  6	0.0118825714610463	0.177748568968847	6	0	3932	4303	2.09268664296597
R-HSA-182971	EGFR downregulation	 23	0.029071050208216	0.266975277545073	16	7	3922	4296	1.45578201249807
R-HSA-1834941	STING mediated induction of host immune responses	 14	0.538655708122675	0.996925296538267	7	7	3931	4296	1.04634332148299
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA 	 61	0.194267237960002	0.669358877079889	33	28	3905	4275	1.13210916750618
R-HSA-1839117	Signaling by cytosolic FGFR1 fusion mutants	 17	0.0496310251439019	0.336506347045761	12	5	3926	4298	1.47719057150539
R-HSA-1839122	Signaling by activated point mutants of FGFR1	 10	0.998501207270849	1	1	9	3937	4294	0.209268664296597
R-HSA-1839124	FGFR1 mutant receptor activation	 29	0.692316768513358	1	13	16	3925	4287	0.938100908915781
R-HSA-1839126	FGFR2 mutant receptor activation	 26	0.875316764747432	1	10	16	3928	4287	0.804879478063836
R-HSA-1839130	Signaling by activated point mutants of FGFR3	 10	0.998501207270849	1	1	9	3937	4294	0.209268664296597
R-HSA-1855167	Synthesis of pyrophosphates in the cytosol	 10	0.137803517982411	0.566564079971367	7	3	3931	4300	1.46488065007618
R-HSA-1855183	Synthesis of IP2, IP, and Ins in the cytosol	 14	0.33187102925713	0.818236200316395	8	6	3930	4297	1.1958209388377
R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol	 24	0.652666486736953	1	11	13	3927	4290	0.959148044692737
R-HSA-186712	Regulation of beta-cell development	 23	0.990582476502306	1	6	17	3932	4286	0.545918254686775
R-HSA-186763	Downstream signal transduction	 27	0.0823170472148334	0.455885631712684	17	10	3921	4293	1.31761751594154
R-HSA-186797	Signaling by PDGF	 53	0.480113870486876	0.944007230255498	26	27	3912	4276	1.02660099466255
R-HSA-187015	Activation of TRKA receptors	  5	0.78366872375152	1	2	3	3936	4300	0.837074657186389
R-HSA-187037	NGF signalling via TRKA from the plasma membrane	 75	0.00330158537663191	0.0840456207279455	48	27	3890	4276	1.33931945149822
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	 50	0.430854971423198	0.918433256168249	25	25	3913	4278	1.04634332148299
R-HSA-187687	Signalling to ERKs	 31	0.543786508967524	1	15	16	3923	4287	1.01259031111257
R-HSA-187706	Signalling to p38 via RIT and RIN	  5	0.458521658108405	0.918433256168249	3	2	3935	4301	1.25561198577958
R-HSA-189200	Cellular hexose transport	 16	0.996480257591012	1	3	13	3935	4290	0.39237874555612
R-HSA-189445	Metabolism of porphyrins	 15	0.113632089157941	0.530161290572901	10	5	3928	4298	1.39512442864398
R-HSA-189451	Heme biosynthesis	 11	0.087058396650189	0.464288021493932	8	3	3930	4300	1.52195392215707
R-HSA-190236	Signaling by FGFR	 75	0.139562931728667	0.566564079971367	41	34	3897	4269	1.14400203148807
R-HSA-190239	FGFR3 ligand binding and activation	 11	0.999218282446089	1	1	10	3937	4293	0.190244240269634
R-HSA-190241	FGFR2 ligand binding and activation	 14	0.99846476742548	1	2	12	3936	4291	0.298955234709425
R-HSA-190242	FGFR1 ligand binding and activation	 13	0.99978742059131	1	1	12	3937	4291	0.160975895612767
R-HSA-190322	FGFR4 ligand binding and activation	 10	1	1	0	10	3938	4293	0
R-HSA-190371	FGFR3b ligand binding and activation	  6	0.979768658250007	1	1	5	3937	4298	0.348781107160995
R-HSA-190372	FGFR3c ligand binding and activation	 11	0.999218282446089	1	1	10	3937	4293	0.190244240269634
R-HSA-190373	FGFR1c ligand binding and activation	 11	0.999218282446089	1	1	10	3937	4293	0.190244240269634
R-HSA-190375	FGFR2c ligand binding and activation	 11	0.999218282446089	1	1	10	3937	4293	0.190244240269634
R-HSA-190377	FGFR2b ligand binding and activation	  6	0.86854805730333	1	2	4	3936	4299	0.697562214321991
R-HSA-190828	Gap junction trafficking	 37	0.392824418800691	0.918433256168249	19	18	3919	4285	1.07462287071226
R-HSA-190840	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	 13	0.651619464532439	1	6	7	3932	4296	0.965855373676603
R-HSA-190861	Gap junction assembly	 27	0.956787270479453	1	9	18	3929	4285	0.697562214321991
R-HSA-190872	Transport of connexons to the plasma membrane	 14	0.736342281839761	1	6	8	3932	4295	0.896865704128274
R-HSA-190873	Gap junction degradation	 11	0.000294498102604737	0.0220513146360007	11	0	3927	4303	2.09268664296597
R-HSA-1912399	Pre-NOTCH Processing in the Endoplasmic Reticulum	  5	0.458521658108405	0.918433256168249	3	2	3935	4301	1.25561198577958
R-HSA-1912408	Pre-NOTCH Transcription and Translation	 29	0.0873539833686033	0.464288021493932	18	11	3920	4292	1.29890895080647
R-HSA-1912420	Pre-NOTCH Processing in Golgi	 18	0.517590085596515	0.97535482363707	9	9	3929	4294	1.04634332148299
R-HSA-1912422	Pre-NOTCH Expression and Processing	 44	0.0878293271901019	0.465110780119846	26	18	3912	4285	1.23658756175262
R-HSA-191273	Cholesterol biosynthesis	 24	0.0490245166606896	0.334726440078746	16	8	3922	4295	1.39512442864398
R-HSA-191859	snRNP Assembly	 47	0.274802327591016	0.772928726676344	25	22	3913	4281	1.11313119306701
R-HSA-192105	Synthesis of bile acids and bile salts	 28	0.629311627077588	1	13	15	3925	4288	0.97160451280563
R-HSA-192823	Viral mRNA Translation	 43	0.624798444222717	1	20	23	3918	4280	0.973342624635336
R-HSA-193048	Androgen biosynthesis	  8	0.31592015436873	0.818236200316395	5	3	3933	4300	1.30792915185373
R-HSA-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	 18	0.839440366169065	1	7	11	3931	4292	0.813822583375656
R-HSA-193634	Axonal growth inhibition (RHOA activation)	  9	0.700733355278605	1	4	5	3934	4298	0.930082952429321
R-HSA-193639	p75NTR signals via NF-kB	 15	0.805145315275593	1	6	9	3932	4294	0.837074657186389
R-HSA-193648	NRAGE signals death through JNK	 52	0.154593896479566	0.598175316778266	29	23	3909	4280	1.16707524319256
R-HSA-193670	p75NTR negatively regulates cell cycle via SC1	  6	0.979768658250007	1	1	5	3937	4298	0.348781107160995
R-HSA-193692	Regulated proteolysis of p75NTR	 10	0.323700113595242	0.818236200316395	6	4	3932	4299	1.25561198577958
R-HSA-193697	p75NTR regulates axonogenesis	 10	0.789532131800886	1	4	6	3934	4297	0.837074657186389
R-HSA-193704	p75 NTR receptor-mediated signalling	 87	0.100521927281924	0.49578463748403	48	39	3890	4264	1.15458573405019
R-HSA-193775	Synthesis of bile acids and bile salts via 24-hydroxycholesterol	 10	0.998501207270849	1	1	9	3937	4294	0.209268664296597
R-HSA-193807	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	 10	0.789532131800886	1	4	6	3934	4297	0.837074657186389
R-HSA-194002	Glucocorticoid biosynthesis	  5	0.961231891425561	1	1	4	3937	4299	0.418537328593195
R-HSA-194068	Bile acid and bile salt metabolism	 33	0.536329851735486	0.996925296538267	16	17	3922	4286	1.01463594810471
R-HSA-194138	Signaling by VEGF	100	0.442262902771148	0.918433256168249	49	51	3889	4252	1.02541645505333
R-HSA-194313	VEGF ligand-receptor interactions	  6	0.86854805730333	1	2	4	3936	4299	0.697562214321991
R-HSA-194441	Metabolism of non-coding RNA	 47	0.274802327591016	0.772928726676344	25	22	3913	4281	1.11313119306701
R-HSA-195253	Degradation of beta-catenin by the destruction complex	 75	0.0943538482556424	0.482068428939919	42	33	3896	4270	1.17190452006094
R-HSA-195399	VEGF binds to VEGFR leading to receptor dimerization	  6	0.86854805730333	1	2	4	3936	4299	0.697562214321991
R-HSA-196025	Formation of annular gap junctions	 10	0.000617111477224947	0.0304713721795	10	0	3928	4303	2.09268664296597
R-HSA-196071	Metabolism of steroid hormones	 25	0.717893653067638	1	11	14	3927	4289	0.920782122905028
R-HSA-196108	Pregnenolone biosynthesis	 10	0.567535190495185	1	5	5	3933	4298	1.04634332148299
R-HSA-196299	Beta-catenin phosphorylation cascade	 17	0.0156736968712207	0.197568507635796	13	4	3925	4299	1.60028978579751
R-HSA-1963640	GRB2 events in ERBB2 signaling	 13	0.10148038410252	0.49578463748403	9	4	3929	4299	1.4487830605149
R-HSA-1963642	PI3K events in ERBB2 signaling	 13	0.10148038410252	0.49578463748403	9	4	3929	4299	1.4487830605149
R-HSA-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism	 18	0.517590085596515	0.97535482363707	9	9	3929	4294	1.04634332148299
R-HSA-196757	Metabolism of folate and pterines	 10	0.323700113595242	0.818236200316395	6	4	3932	4299	1.25561198577958
R-HSA-196780	Biotin transport and metabolism	 11	0.226607480313798	0.719491146466787	7	4	3931	4299	1.33170968188744
R-HSA-196783	Coenzyme A biosynthesis	  8	0.31592015436873	0.818236200316395	5	3	3933	4300	1.30792915185373
R-HSA-196807	Nicotinate metabolism	 29	0.551766837618177	1	14	15	3924	4288	1.01026251729392
R-HSA-196836	Vitamin C (ascorbate) metabolism	  8	0.824577748049705	1	3	5	3935	4298	0.78475749111224
R-HSA-196843	Vitamin B2 (riboflavin) metabolism	  7	0.451634376327358	0.918433256168249	4	3	3934	4300	1.1958209388377
R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	 26	0.640506040097296	1	12	14	3926	4289	0.965855373676603
R-HSA-197264	Nicotinamide salvaging	 17	0.899918550187916	1	6	11	3932	4292	0.738595285752696
R-HSA-1980143	Signaling by NOTCH1	 69	0.0904872412892101	0.473996343359725	39	30	3899	4273	1.18282288515468
R-HSA-1980145	Signaling by NOTCH2	 29	0.0415356946138425	0.32057602598237	19	10	3919	4293	1.3710705591846
R-HSA-1980148	Signaling by NOTCH3	 11	0.0232714841058113	0.24468785099661	9	2	3929	4301	1.7121981624267
R-HSA-1980150	Signaling by NOTCH4	 11	0.087058396650189	0.464288021493932	8	3	3930	4300	1.52195392215707
R-HSA-198203	PI3K/AKT activation	  8	0.587348598285987	1	4	4	3934	4299	1.04634332148299
R-HSA-198323	AKT phosphorylates targets in the cytosol	 13	0.237285205121634	0.72945091659214	8	5	3930	4298	1.28780716490214
R-HSA-198693	AKT phosphorylates targets in the nucleus	  9	0.445617652045213	0.918433256168249	5	4	3933	4299	1.16260369053665
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	 25	0.0333800956286754	0.286594785545609	17	8	3921	4295	1.42302691721686
R-HSA-198753	ERK/MAPK targets	 22	0.0436098425970425	0.329572300043275	15	7	3923	4296	1.42683180202225
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	100	1	1	10	90	3928	4213	0.209268664296597
R-HSA-199220	Vitamin B5 (pantothenate) metabolism	 15	0.113632089157941	0.530161290572901	10	5	3928	4298	1.39512442864398
R-HSA-199418	Negative regulation of the PI3K/AKT network	 86	0.887928283324548	1	36	50	3902	4253	0.876008362171802
R-HSA-199920	CREB phosphorylation	  7	0.451634376327358	0.918433256168249	4	3	3934	4300	1.1958209388377
R-HSA-199992	trans-Golgi Network Vesicle Budding	 63	0.000115275989746125	0.0128665739324329	45	18	3893	4285	1.49477617354712
R-HSA-200425	Import of palmitoyl-CoA into the mitochondrial matrix	 13	0.936367727562474	1	4	9	3934	4294	0.643903582451068
R-HSA-201451	Signaling by BMP	 27	0.268555902371867	0.772928726676344	15	12	3923	4291	1.16260369053665
R-HSA-201688	WNT mediated activation of DVL	  7	0.989443342380119	1	1	6	3937	4297	0.298955234709425
R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	 51	0.994264703411632	1	16	35	3922	4268	0.656529142891285
R-HSA-202040	G-protein activation	 21	0.590936188394649	1	10	11	3928	4292	0.996517449031415
R-HSA-202131	Metabolism of nitric oxide	 18	0.517590085596515	0.97535482363707	9	9	3929	4294	1.04634332148299
R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	 52	0.932539916272709	1	20	32	3918	4271	0.804879478063836
R-HSA-2022377	Metabolism of Angiotensinogen to Angiotensins	 12	0.99510376956634	1	2	10	3936	4293	0.348781107160995
R-HSA-2022854	Keratan sulfate biosynthesis	 25	0.917564909912096	1	9	16	3929	4287	0.75336719146775
R-HSA-2022857	Keratan sulfate degradation	 11	0.991330455518455	1	2	9	3936	4294	0.380488480539268
R-HSA-2022870	Chondroitin sulfate biosynthesis	 18	0.69696919215368	1	8	10	3930	4293	0.930082952429321
R-HSA-2022923	Dermatan sulfate biosynthesis	 11	0.67363845463036	1	5	6	3933	4297	0.951221201348169
R-HSA-2022928	HS-GAG biosynthesis	 27	0.906220184038908	1	10	17	3928	4286	0.775069127024434
R-HSA-202403	TCR signaling	 94	0.228377721705681	0.719761606298485	49	45	3889	4258	1.09086856920567
R-HSA-2024096	HS-GAG degradation	 22	0.901961873278792	1	8	14	3930	4289	0.760976961078535
R-HSA-2024101	CS/DS degradation	 14	0.538655708122675	0.996925296538267	7	7	3931	4296	1.04634332148299
R-HSA-202424	Downstream TCR signaling	 77	0.197800665942672	0.669358877079889	41	36	3897	4267	1.11428769300786
R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	 14	0.958809377392206	1	4	10	3934	4293	0.597910469418849
R-HSA-202430	Translocation of ZAP-70 to Immunological synapse	 11	0.955170261510425	1	3	8	3935	4295	0.570732720808902
R-HSA-202433	Generation of second messenger molecules	 23	0.732261729866932	1	10	13	3928	4290	0.909863757811292
R-HSA-2025928	Calcineurin activates NFAT	  8	0.117259782578872	0.535576201184411	6	2	3932	4301	1.56951498222448
R-HSA-202670	ERKs are inactivated	 13	0.0325091832282712	0.284161595567599	10	3	3928	4300	1.60975895612767
R-HSA-2028269	Signaling by Hippo	 20	0.335847459195257	0.818236200316395	11	9	3927	4294	1.15097765363129
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	 87	0.420244148748875	0.918433256168249	43	44	3895	4259	1.0343163867533
R-HSA-2029481	FCGR activation	 17	0.999739138400515	1	2	15	3936	4288	0.246198428584232
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	 63	0.459475819569822	0.918433256168249	31	32	3907	4271	1.02973469733246
R-HSA-2029485	Role of phospholipids in phagocytosis	 29	0.949005170917345	1	10	19	3928	4284	0.72161608378137
R-HSA-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression	 25	0.0333800956286754	0.286594785545609	17	8	3921	4295	1.42302691721686
R-HSA-2033514	FGFR3 mutant receptor activation	 10	0.998501207270849	1	1	9	3937	4294	0.209268664296597
R-HSA-2033519	Activated point mutants of FGFR2	 12	0.99959232907152	1	1	11	3937	4292	0.174390553580498
R-HSA-203615	eNOS activation	 10	0.323700113595242	0.818236200316395	6	4	3932	4299	1.25561198577958
R-HSA-203765	eNOS activation and regulation	 18	0.517590085596515	0.97535482363707	9	9	3929	4294	1.04634332148299
R-HSA-203927	MicroRNA (miRNA) biogenesis	 21	0.00191966005977888	0.0625431344392312	17	4	3921	4299	1.69407966335341
R-HSA-204005	COPII (Coat Protein 2) Mediated Vesicle Transport	 60	0.0209980729508567	0.22480392240626	37	23	3901	4280	1.29049009649568
R-HSA-204174	Regulation of pyruvate dehydrogenase (PDH) complex	 14	0.065444021370581	0.396062653800984	10	4	3928	4299	1.49477617354712
R-HSA-2046104	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	  9	0.212162156227543	0.693349749293164	6	3	3932	4300	1.39512442864398
R-HSA-2046105	Linoleic acid (LA) metabolism	  5	0.78366872375152	1	2	3	3936	4300	0.837074657186389
R-HSA-2046106	alpha-linolenic acid (ALA) metabolism	  9	0.212162156227543	0.693349749293164	6	3	3932	4300	1.39512442864398
R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	 67	0.0556360096485535	0.365284389140503	39	28	3899	4275	1.21813103098019
R-HSA-205025	NADE modulates death signalling	  6	0.86854805730333	1	2	4	3936	4299	0.697562214321991
R-HSA-205043	NRIF signals cell death from the nucleus	 14	0.166345837020011	0.618228588257232	9	5	3929	4298	1.34529855619241
R-HSA-209543	p75NTR recruits signalling complexes	 12	0.760692490142898	1	5	7	3933	4296	0.871952767902489
R-HSA-209560	NF-kB is activated and signals survival	 12	0.760692490142898	1	5	7	3933	4296	0.871952767902489
R-HSA-209776	Amine-derived hormones	 10	0.984755874789722	1	2	8	3936	4295	0.418537328593195
R-HSA-209822	Glycoprotein hormones	  7	0.921720553469337	1	2	5	3936	4298	0.597910469418849
R-HSA-209952	Peptide hormone biosynthesis	  9	0.886499944435254	1	3	6	3935	4297	0.697562214321991
R-HSA-209968	Thyroxine biosynthesis	  7	0.921720553469337	1	2	5	3936	4298	0.597910469418849
R-HSA-210500	Glutamate Neurotransmitter Release Cycle	 24	0.00035848125089819	0.0220513146360007	20	4	3918	4299	1.74390553580498
R-HSA-210744	Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	  6	0.979768658250007	1	1	5	3937	4298	0.348781107160995
R-HSA-210745	Regulation of gene expression in beta cells	 15	0.97371360668231	1	4	11	3934	4292	0.558049771457593
R-HSA-210747	Regulation of gene expression in early pancreatic precursor cells	  5	1	1	0	5	3938	4298	0
R-HSA-210990	PECAM1 interactions	 11	0.67363845463036	1	5	6	3933	4297	0.951221201348169
R-HSA-210991	Basigin interactions	 20	0.915906277694761	1	7	13	3931	4290	0.73244032503809
R-HSA-210993	Tie2 Signaling	 16	0.33392496716077	0.818236200316395	9	7	3929	4296	1.17713623666836
R-HSA-211000	Gene Silencing by RNA	 87	0.0675368272500747	0.406622142489039	49	38	3889	4265	1.17863960350957
R-HSA-211227	Activation of DNA fragmentation factor	 12	0.903289390204616	1	4	8	3934	4295	0.697562214321991
R-HSA-211733	Regulation of activated PAK-2p34 by proteasome mediated degradation	 41	0.387373974931738	0.918433256168249	21	20	3917	4283	1.07186389029964
R-HSA-211897	Cytochrome P450 - arranged by substrate type	 43	0.96896041010967	1	15	28	3923	4275	0.730006968476502
R-HSA-211935	Fatty acids	  8	1	1	0	8	3938	4295	0
R-HSA-211945	Phase I - Functionalization of compounds	 79	0.990313183095205	1	28	51	3910	4252	0.74171172155756
R-HSA-211958	Miscellaneous substrates	  8	0.994492178633106	1	1	7	3937	4296	0.261585830370747
R-HSA-211976	Endogenous sterols	 19	0.765077447663163	1	8	11	3930	4292	0.881131218090936
R-HSA-211979	Eicosanoids	  8	1	1	0	8	3938	4295	0
R-HSA-211981	Xenobiotics	 15	0.994034112436162	1	3	12	3935	4291	0.418537328593194
R-HSA-211999	CYP2E1 reactions	  6	0.86854805730333	1	2	4	3936	4299	0.697562214321991
R-HSA-212165	Epigenetic regulation of gene expression	 96	0.227954203245783	0.719761606298485	50	46	3888	4257	1.08994095987811
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	 45	0.38219712419891	0.913621132145993	23	22	3915	4281	1.06959539529372
R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	 28	0.0589150455208208	0.383344085429197	18	10	3920	4293	1.34529855619241
R-HSA-212300	PRC2 methylates histones and DNA	 30	0.920870151787637	1	11	19	3927	4284	0.76731843575419
R-HSA-212676	Dopamine Neurotransmitter Release Cycle	 21	0.000364735734847703	0.0220513146360007	18	3	3920	4300	1.79373140825655
R-HSA-2129379	Molecules associated with elastic fibres	 31	0.999764501502288	1	6	25	3932	4278	0.405036124445027
R-HSA-2132295	MHC class II antigen presentation	 97	0.146264065221765	0.573853740440181	52	45	3886	4258	1.12185263334258
R-HSA-2142670	Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)	  6	0.613910056647902	1	3	3	3935	4300	1.04634332148299
R-HSA-2142688	Synthesis of 5-eicosatetraenoic acids	  7	0.921720553469337	1	2	5	3936	4298	0.597910469418849
R-HSA-2142691	Synthesis of Leukotrienes (LT) and Eoxins (EX)	 17	0.997938385280364	1	3	14	3935	4289	0.369297642876348
R-HSA-2142700	Synthesis of Lipoxins (LX)	  5	0.78366872375152	1	2	3	3936	4300	0.837074657186389
R-HSA-2142712	Synthesis of 12-eicosatetraenoic acid derivatives	  6	0.86854805730333	1	2	4	3936	4299	0.697562214321991
R-HSA-2142753	Arachidonic acid metabolism	 46	0.997881880819497	1	13	33	3925	4270	0.59141144257734
R-HSA-2142789	Ubiquinol biosynthesis	  7	0.451634376327358	0.918433256168249	4	3	3934	4300	1.1958209388377
R-HSA-2142816	Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)	  6	0.613910056647902	1	3	3	3935	4300	1.04634332148299
R-HSA-2142845	Hyaluronan metabolism	 14	0.958809377392206	1	4	10	3934	4293	0.597910469418849
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	 52	0.00344253431362821	0.0846630048995682	35	17	3903	4286	1.40853908661171
R-HSA-2151209	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	 10	0.323700113595242	0.818236200316395	6	4	3932	4299	1.25561198577958
R-HSA-216083	Integrin cell surface interactions	 69	0.998910305754138	1	21	48	3917	4255	0.636904630467905
R-HSA-2160916	Hyaluronan uptake and degradation	 10	0.928057578421412	1	3	7	3935	4296	0.627805992889792
R-HSA-2161522	Abacavir transport and metabolism	  9	0.97341621551606	1	2	7	3936	4296	0.465041476214661
R-HSA-2161541	Abacavir metabolism	  5	0.78366872375152	1	2	3	3936	4300	0.837074657186389
R-HSA-2162123	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	 12	0.99510376956634	1	2	10	3936	4293	0.348781107160995
R-HSA-2168880	Scavenging of heme from plasma	 18	0.999856502660292	1	2	16	3936	4287	0.23252073810733
R-HSA-2172127	DAP12 interactions	 30	0.963072680482199	1	10	20	3928	4283	0.697562214321991
R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors	 45	0.999994284516094	1	8	37	3930	4266	0.372033180971728
R-HSA-2173788	Downregulation of TGF-beta receptor signaling	 24	0.652666486736953	1	11	13	3927	4290	0.959148044692737
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	 30	0.474992990458817	0.940265796938258	15	15	3923	4288	1.04634332148299
R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	 13	0.936367727562474	1	4	9	3934	4294	0.643903582451068
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	 42	0.0849813110255175	0.464288021493932	25	17	3913	4286	1.24564681128927
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	 22	0.100707670695172	0.49578463748403	14	8	3924	4295	1.33170968188744
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	 30	0.33447966198245	0.818236200316395	16	14	3922	4289	1.11609954291519
R-HSA-2179392	EGFR Transactivation by Gastrin	  8	0.0264284361188029	0.255651072055887	7	1	3931	4302	1.83110081259523
R-HSA-2187338	Visual phototransduction	 82	0.999921607201052	1	23	59	3915	4244	0.586973082783139
R-HSA-2197563	NOTCH2 intracellular domain regulates transcription	 11	0.440211273532975	0.918433256168249	6	5	3932	4298	1.1414654416178
R-HSA-2206281	Mucopolysaccharidoses	 11	0.855757090184043	1	4	7	3934	4296	0.760976961078535
R-HSA-2214320	Anchoring fibril formation	 13	0.828863131149436	1	5	8	3933	4295	0.804879478063836
R-HSA-2219528	PI3K/AKT Signaling in Cancer	 75	0.780650454125035	1	33	42	3905	4261	0.920782122905028
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	 50	0.966179336970532	1	18	32	3920	4271	0.75336719146775
R-HSA-2243919	Crosslinking of collagen fibrils	 16	0.859018441747778	1	6	10	3932	4293	0.78475749111224
R-HSA-2262749	Cellular response to hypoxia	 64	0.606405507712536	1	30	34	3908	4269	0.9809468638903
R-HSA-2299718	Condensation of Prophase Chromosomes	 32	0.997707706059792	1	8	24	3930	4279	0.523171660741493
R-HSA-2393930	Phosphate bond hydrolysis by NUDT proteins	  7	0.451634376327358	0.918433256168249	4	3	3934	4300	1.1958209388377
R-HSA-2404192	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	 41	0.387373974931738	0.918433256168249	21	20	3917	4283	1.07186389029964
R-HSA-2408508	Metabolism of ingested SeMet, Sec, MeSec into H2Se	  6	0.86854805730333	1	2	4	3936	4299	0.697562214321991
R-HSA-2408517	SeMet incorporation into proteins	 10	0.137803517982411	0.566564079971367	7	3	3931	4300	1.46488065007618
R-HSA-2408522	Selenoamino acid metabolism	 68	0.498717615626916	0.96514067506474	33	35	3905	4268	1.01556851790996
R-HSA-2408557	Selenocysteine synthesis	 47	0.49437775469763	0.959013532174145	23	24	3915	4279	1.02408069762165
R-HSA-2424491	DAP12 signaling	 24	0.888416350583373	1	9	15	3929	4288	0.78475749111224
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	 40	2.83595308213503e-05	0.00587852560311132	32	8	3906	4295	1.67414931437278
R-HSA-2428924	IGF1R signaling cascade	 40	0.329655421749318	0.818236200316395	21	19	3917	4284	1.09866048755714
R-HSA-2428928	IRS-related events triggered by IGF1R	 39	0.274409173540982	0.772928726676344	21	18	3917	4285	1.12683126928937
R-HSA-2428933	SHC-related events triggered by IGF1R	  9	0.0698085957545361	0.416325844741537	7	2	3931	4301	1.62764516675131
R-HSA-2453864	Retinoid cycle disease events	  8	0.824577748049705	1	3	5	3935	4298	0.78475749111224
R-HSA-2453902	The canonical retinoid cycle in rods (twilight vision)	 20	0.989973682689048	1	5	15	3933	4288	0.523171660741493
R-HSA-2465910	MASTL Facilitates Mitotic Progression	 10	0.137803517982411	0.566564079971367	7	3	3931	4300	1.46488065007618
R-HSA-2468052	Establishment of Sister Chromatid Cohesion	 10	0.567535190495185	1	5	5	3933	4298	1.04634332148299
R-HSA-2470946	Cohesin Loading onto Chromatin	 10	0.137803517982411	0.566564079971367	7	3	3931	4300	1.46488065007618
R-HSA-2474795	Diseases associated with visual transduction	  8	0.824577748049705	1	3	5	3935	4298	0.78475749111224
R-HSA-2485179	Activation of the phototransduction cascade	 10	0.998501207270849	1	1	9	3937	4294	0.209268664296597
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	 98	0.606016008729137	1	46	52	3892	4251	0.982281485473824
R-HSA-2514853	Condensation of Prometaphase Chromosomes	  8	0.824577748049705	1	3	5	3935	4298	0.78475749111224
R-HSA-2514856	The phototransduction cascade	 29	0.895073150120621	1	11	18	3927	4285	0.793777692159507
R-HSA-2514859	Inactivation, recovery and regulation of the phototransduction cascade	 28	0.862682255048791	1	11	17	3927	4286	0.822126895450918
R-HSA-2559580	Oxidative Stress Induced Senescence	 75	0.349459083052984	0.849355325812194	38	37	3900	4266	1.06029456576943
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	 62	0.981682370646401	1	22	40	3916	4263	0.742566228149216
R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	 14	0.958809377392206	1	4	10	3934	4293	0.597910469418849
R-HSA-2559585	Oncogene Induced Senescence	 30	0.0288733224043334	0.266975277545073	20	10	3918	4293	1.39512442864398
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	 46	0.997881880819497	1	13	33	3925	4270	0.59141144257734
R-HSA-2562578	TRIF-mediated programmed cell death	  8	0.994492178633106	1	1	7	3937	4296	0.261585830370747
R-HSA-2564830	Cytosolic iron-sulfur cluster assembly	  9	0.445617652045213	0.918433256168249	5	4	3933	4299	1.16260369053665
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	 83	0.00825776973127743	0.147926220741772	51	32	3887	4271	1.2858676962803
R-HSA-2586552	Signaling by Leptin	 10	0.137803517982411	0.566564079971367	7	3	3931	4300	1.46488065007618
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	 55	0.0459831319780975	0.334726440078746	33	22	3905	4281	1.25561198577958
R-HSA-2644603	Signaling by NOTCH1 in Cancer	 55	0.0459831319780975	0.334726440078746	33	22	3905	4281	1.25561198577958
R-HSA-2644605	FBXW7 Mutants and NOTCH1 in Cancer	  5	0.458521658108405	0.918433256168249	3	2	3935	4301	1.25561198577958
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	 55	0.0459831319780975	0.334726440078746	33	22	3905	4281	1.25561198577958
R-HSA-2644607	Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling	  5	0.458521658108405	0.918433256168249	3	2	3935	4301	1.25561198577958
R-HSA-264642	Acetylcholine Neurotransmitter Release Cycle	 15	0.00219121140291024	0.0637901629168669	13	2	3925	4301	1.81366175723718
R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	 12	0.760692490142898	1	5	7	3933	4296	0.871952767902489
R-HSA-264876	Insulin processing	 28	0.0256663595205851	0.255081422358691	19	9	3919	4294	1.42003736486977
R-HSA-2660825	Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	  7	0.451634376327358	0.918433256168249	4	3	3934	4300	1.1958209388377
R-HSA-2660826	Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	  7	0.451634376327358	0.918433256168249	4	3	3934	4300	1.1958209388377
R-HSA-2672351	Stimuli-sensing channels	 86	0.300630340098152	0.818236200316395	44	42	3894	4261	1.07067688709887
R-HSA-2682334	EPH-Ephrin signaling	 86	0.00658792093889136	0.129176665977451	53	33	3885	4270	1.28967897764182
R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer	 14	0.33187102925713	0.818236200316395	8	6	3930	4297	1.1958209388377
R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	 14	0.33187102925713	0.818236200316395	8	6	3930	4297	1.1958209388377
R-HSA-2730905	Role of LAT2/NTAL/LAB on calcium mobilization	 25	0.996080471840313	1	6	19	3932	4284	0.502244794311833
R-HSA-2871796	FCERI mediated MAPK activation	 41	0.972968380687063	1	14	27	3924	4276	0.71457592686643
R-HSA-2871809	FCERI mediated Ca+2 mobilization	 37	0.991950412077422	1	11	26	3927	4277	0.622150083043938
R-HSA-2871837	FCERI mediated NF-kB activation	 80	0.729810452946482	1	36	44	3902	4259	0.941708989334688
R-HSA-2892245	POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation	  6	0.613910056647902	1	3	3	3935	4300	1.04634332148299
R-HSA-2892247	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	  8	0.824577748049705	1	3	5	3935	4298	0.78475749111224
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	 55	0.0459831319780975	0.334726440078746	33	22	3905	4281	1.25561198577958
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	 55	0.0459831319780975	0.334726440078746	33	22	3905	4281	1.25561198577958
R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	 19	0.0201525213104117	0.223179876742724	14	5	3924	4298	1.54197963165914
R-HSA-2980736	Peptide hormone metabolism	 67	0.196075910130482	0.669358877079889	36	31	3902	4272	1.12442864398172
R-HSA-2980766	Nuclear Envelope Breakdown	 50	0.543509134552689	1	24	26	3914	4277	1.00448958862367
R-HSA-2980767	Activation of NIMA Kinases NEK9, NEK6, NEK7	  7	0.989443342380119	1	1	6	3937	4297	0.298955234709425
R-HSA-2993913	Clearance of Nuclear Envelope Membranes from Chromatin	  8	0.824577748049705	1	3	5	3935	4298	0.78475749111224
R-HSA-2995383	Initiation of Nuclear Envelope Reformation	 12	0.328659742153142	0.818236200316395	7	5	3931	4298	1.22073387506348
R-HSA-2995410	Nuclear Envelope Reassembly	 12	0.328659742153142	0.818236200316395	7	5	3931	4298	1.22073387506348
R-HSA-3000157	Laminin interactions	 26	0.77464456924589	1	11	15	3927	4288	0.885367425870219
R-HSA-3000170	Syndecan interactions	 25	0.964324329850068	1	8	17	3930	4286	0.669659725749111
R-HSA-3000171	Non-integrin membrane-ECM interactions	 54	0.880578904132087	1	22	32	3916	4271	0.852576039726878
R-HSA-3000178	ECM proteoglycans	 58	0.867118488533731	1	24	34	3914	4269	0.865939300537644
R-HSA-3000471	Scavenging by Class B Receptors	  5	1	1	0	5	3938	4298	0
R-HSA-3000480	Scavenging by Class A Receptors	 18	0.993629190070664	1	4	14	3934	4289	0.465041476214661
R-HSA-3000484	Scavenging by Class F Receptors	  6	0.613910056647902	1	3	3	3935	4300	1.04634332148299
R-HSA-3065676	SUMO is conjugated to E1 (UBA2:SAE1)	  5	0.78366872375152	1	2	3	3936	4300	0.837074657186389
R-HSA-3065678	SUMO is transferred from E1 to E2 (UBE2I, UBC9)	  6	0.86854805730333	1	2	4	3936	4299	0.697562214321991
R-HSA-3065679	SUMO is proteolytically processed	  5	0.160967868205754	0.608240564496221	4	1	3934	4302	1.67414931437278
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	 71	0.0918424035832088	0.478682982083076	40	31	3898	4272	1.17897839040336
R-HSA-3134963	DEx/H-box helicases activate type I IFN and inflammatory cytokines production 	 11	0.855757090184043	1	4	7	3934	4296	0.760976961078535
R-HSA-3134973	LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production	  5	0.458521658108405	0.918433256168249	3	2	3935	4301	1.25561198577958
R-HSA-3134975	Regulation of innate immune responses to cytosolic DNA	 13	0.651619464532439	1	6	7	3932	4296	0.965855373676603
R-HSA-3214815	HDACs deacetylate histones	 49	0.977252006606517	1	17	32	3921	4271	0.726034141437174
R-HSA-3214841	PKMTs methylate histone lysines	 44	0.0247983901516253	0.252484197298917	28	16	3910	4287	1.33170968188744
R-HSA-3214842	HDMs demethylate histones	 27	0.906220184038908	1	10	17	3928	4286	0.775069127024434
R-HSA-3214847	HATs acetylate histones	 93	0.198291575203208	0.669358877079889	49	44	3889	4259	1.10259833876702
R-HSA-3214858	RMTs methylate histone arginines	 39	0.641463892296054	1	18	21	3920	4282	0.965855373676603
R-HSA-3215018	Processing and activation of SUMO	  8	0.587348598285987	1	4	4	3934	4299	1.04634332148299
R-HSA-3229121	Glycogen storage diseases	 12	0.760692490142898	1	5	7	3933	4296	0.871952767902489
R-HSA-3232118	SUMOylation of transcription factors	 17	0.251740288609141	0.764173972326076	10	7	3928	4296	1.23099214292116
R-HSA-3238698	WNT ligand biogenesis and trafficking	 21	0.993640442773991	1	5	16	3933	4287	0.498258724515708
R-HSA-3270619	IRF3-mediated induction of type I IFN	 11	0.440211273532975	0.918433256168249	6	5	3932	4298	1.1414654416178
R-HSA-3295583	TRP channels	 21	0.866574233666673	1	8	13	3930	4290	0.797213959225132
R-HSA-3296469	Defects in cobalamin (B12) metabolism	 12	0.328659742153142	0.818236200316395	7	5	3931	4298	1.22073387506348
R-HSA-3296482	Defects in vitamin and cofactor metabolism	 20	0.0933613259335015	0.478682982083076	13	7	3925	4296	1.36024631792788
R-HSA-3299685	Detoxification of Reactive Oxygen Species	 31	0.884162955739711	1	12	19	3926	4284	0.810072248890054
R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	 34	0.332778119166757	0.818236200316395	18	16	3920	4287	1.10789292862904
R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer	  6	0.613910056647902	1	3	3	3935	4300	1.04634332148299
R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer	  7	0.451634376327358	0.918433256168249	4	3	3934	4300	1.1958209388377
R-HSA-3304356	SMAD2/3 Phosphorylation Motif Mutants in Cancer	  5	0.78366872375152	1	2	3	3936	4300	0.837074657186389
R-HSA-3315487	SMAD2/3 MH2 Domain Mutants in Cancer	  6	0.613910056647902	1	3	3	3935	4300	1.04634332148299
R-HSA-3322077	Glycogen synthesis	 13	0.651619464532439	1	6	7	3932	4296	0.965855373676603
R-HSA-3323169	Defects in biotin (Btn) metabolism	  8	0.117259782578872	0.535576201184411	6	2	3932	4301	1.56951498222448
R-HSA-3371378	Regulation by c-FLIP	 11	0.991330455518455	1	2	9	3936	4294	0.380488480539268
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	 74	0.0284742254476148	0.266975277545073	44	30	3894	4273	1.24430016608788
R-HSA-3371497	HSP90 chaperone cycle for steroid hormone receptors (SHR)	 48	0.324908520532041	0.818236200316395	25	23	3913	4280	1.08994095987811
R-HSA-3371511	HSF1 activation	 25	0.266483735221575	0.772928726676344	14	11	3924	4292	1.17190452006094
R-HSA-3371556	Cellular response to heat stress	 93	0.0178065280963478	0.214544168079219	55	38	3883	4265	1.23761038024869
R-HSA-3371568	Attenuation phase	 22	0.804645864345466	1	9	13	3929	4290	0.856099081213352
R-HSA-3371571	HSF1-dependent transactivation	 32	0.838805425032378	1	13	19	3925	4284	0.850153948704926
R-HSA-3371599	Defective HLCS causes multiple carboxylase deficiency	  7	0.0491362727338201	0.334726440078746	6	1	3932	4302	1.79373140825655
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	 43	0.384753704004467	0.918219777155396	22	21	3916	4282	1.07067688709887
R-HSA-350054	Notch-HLH transcription pathway	 13	0.237285205121634	0.72945091659214	8	5	3930	4298	1.28780716490214
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	 43	0.624798444222717	1	20	23	3918	4280	0.973342624635336
R-HSA-351202	Metabolism of polyamines	 69	0.799394318233717	1	30	39	3908	4264	0.909863757811292
R-HSA-351906	Apoptotic cleavage of cell adhesion  proteins	  8	0.954101488609214	1	2	6	3936	4297	0.523171660741493
R-HSA-352230	Amino acid transport across the plasma membrane	 28	0.969282751164417	1	9	19	3929	4284	0.672649278096205
R-HSA-354192	Integrin alphaIIb beta3 signaling	 24	0.888416350583373	1	9	15	3929	4288	0.78475749111224
R-HSA-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins 	 12	0.760692490142898	1	5	7	3933	4296	0.871952767902489
R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	 37	0.650470456554015	1	17	20	3921	4283	0.961504673795177
R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	 20	0.821370442274037	1	8	12	3930	4291	0.837074657186389
R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	 20	0.680637955746851	1	9	11	3929	4292	0.941708989334688
R-HSA-3595172	Defective CHST3 causes SEDCJD	  8	0.587348598285987	1	4	4	3934	4299	1.04634332148299
R-HSA-3595174	Defective CHST14 causes EDS, musculocontractural type	  8	0.31592015436873	0.818236200316395	5	3	3933	4300	1.30792915185373
R-HSA-3595177	Defective CHSY1 causes TPBS	  8	0.31592015436873	0.818236200316395	5	3	3933	4300	1.30792915185373
R-HSA-3656225	Defective CHST6 causes MCDC1	  6	0.979768658250007	1	1	5	3937	4298	0.348781107160995
R-HSA-3656237	Defective EXT2 causes exostoses 2	 13	0.936367727562474	1	4	9	3934	4294	0.643903582451068
R-HSA-3656243	Defective ST3GAL3 causes MCT12 and EIEE15	  6	0.86854805730333	1	2	4	3936	4299	0.697562214321991
R-HSA-3656244	Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)	  6	0.979768658250007	1	1	5	3937	4298	0.348781107160995
R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	 13	0.828863131149436	1	5	8	3933	4295	0.804879478063836
R-HSA-3656532	TGFBR1 KD Mutants in Cancer	  6	0.613910056647902	1	3	3	3935	4300	1.04634332148299
R-HSA-3656534	Loss of Function of TGFBR1 in Cancer	  6	0.613910056647902	1	3	3	3935	4300	1.04634332148299
R-HSA-372708	p130Cas linkage to MAPK signaling for integrins	 12	0.760692490142898	1	5	7	3933	4296	0.871952767902489
R-HSA-373080	Class B/2 (Secretin family receptors)	 70	0.998196903777492	1	22	48	3916	4255	0.657701516360734
R-HSA-373752	Netrin-1 signaling	 47	0.00903781045808254	0.152486778775323	31	16	3907	4287	1.38028267940309
R-HSA-373753	Nephrin family interactions	 21	0.866574233666673	1	8	13	3930	4290	0.797213959225132
R-HSA-373755	Semaphorin interactions	 59	0.193500629124189	0.66849860204571	32	27	3906	4276	1.13501648432053
R-HSA-375165	NCAM signaling for neurite out-growth	 60	0.414300916184298	0.918433256168249	30	30	3908	4273	1.04634332148299
R-HSA-375170	CDO in myogenesis	 27	0.70462801258257	1	12	15	3926	4288	0.930082952429321
R-HSA-375280	Amine ligand-binding receptors	 31	0.999993327824234	1	4	27	3934	4276	0.270024082963351
R-HSA-376172	DSCAM interactions	 11	0.087058396650189	0.464288021493932	8	3	3930	4300	1.52195392215707
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	 40	0.141348171571078	0.566564079971367	23	17	3915	4286	1.20329481970543
R-HSA-3772470	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	 11	0.955170261510425	1	3	8	3935	4295	0.570732720808902
R-HSA-3781860	Diseases associated with N-glycosylation of proteins	 15	0.91782274684442	1	5	10	3933	4293	0.697562214321991
R-HSA-3785653	Myoclonic epilepsy of Lafora	  8	0.824577748049705	1	3	5	3935	4298	0.78475749111224
R-HSA-379716	Cytosolic tRNA aminoacylation	 23	0.00998613548446982	0.16108520665347	17	6	3921	4297	1.5467683882792
R-HSA-379724	tRNA Aminoacylation	 40	0.043518353786832	0.329572300043275	25	15	3913	4288	1.30792915185373
R-HSA-379726	Mitochondrial tRNA aminoacylation	 19	0.765077447663163	1	8	11	3930	4292	0.881131218090936
R-HSA-380108	Chemokine receptors bind chemokines	 32	0.999855749638822	1	6	26	3932	4277	0.39237874555612
R-HSA-380259	Loss of Nlp from mitotic centrosomes	 67	0.00490478788405785	0.105268297634917	43	24	3895	4279	1.34306754697816
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	 76	0.000499410530847294	0.0262691092032555	51	25	3887	4278	1.40430287883243
R-HSA-380284	Loss of proteins required for interphase microtubule organization from the centrosome	 67	0.00490478788405785	0.105268297634917	43	24	3895	4279	1.34306754697816
R-HSA-380287	Centrosome maturation	 76	0.000499410530847294	0.0262691092032555	51	25	3887	4278	1.40430287883243
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	 85	0.00467598199067138	0.105268297634917	53	32	3885	4271	1.30485167149643
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	 28	0.000852749794851666	0.0386668735103052	22	6	3916	4297	1.64425379090184
R-HSA-380994	ATF4 activates genes	 21	0.0643726891781803	0.396062653800984	14	7	3924	4296	1.39512442864398
R-HSA-381033	ATF6 (ATF6-alpha) activates chaperones	  9	0.0140341047943077	0.190312953799443	8	1	3930	4302	1.86016590485864
R-HSA-381038	XBP1(S) activates chaperone genes	 49	0.188058985415251	0.666494570255742	27	22	3911	4281	1.15311304816492
R-HSA-381042	PERK regulates gene expression	 24	0.202901000970507	0.678362563152547	14	10	3924	4293	1.22073387506348
R-HSA-381070	IRE1alpha activates chaperones	 51	0.27442542500707	0.772928726676344	27	24	3911	4279	1.10789292862904
R-HSA-381119	Unfolded Protein Response (UPR)	 83	0.0655100185473716	0.396062653800984	47	36	3891	4267	1.18501532794459
R-HSA-381183	ATF6 (ATF6-alpha) activates chaperone genes	  7	0.0491362727338201	0.334726440078746	6	1	3932	4302	1.79373140825655
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	 78	0.47871553364363	0.944007230255498	38	40	3900	4263	1.01951400554753
R-HSA-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	 37	0.176185237270617	0.642136623880082	21	16	3917	4287	1.18774106762934
R-HSA-381753	Olfactory Signaling Pathway	 47	0.999498041333765	1	12	35	3926	4268	0.534302972672163
R-HSA-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	 13	0.0325091832282712	0.284161595567599	10	3	3928	4300	1.60975895612767
R-HSA-382556	ABC-family proteins mediated transport	 87	0.420244148748875	0.918433256168249	43	44	3895	4259	1.0343163867533
R-HSA-383280	Nuclear Receptor transcription pathway	 47	0.927520073266699	1	18	29	3920	4274	0.801454459008245
R-HSA-388841	Costimulation by the CD28 family	 60	0.618564085422606	1	28	32	3910	4271	0.976587100050787
R-HSA-388844	Receptor-type tyrosine-protein phosphatases	 18	0.33517537546619	0.818236200316395	10	8	3928	4295	1.16260369053665
R-HSA-389356	CD28 co-stimulation	 33	0.785408522028885	1	14	19	3924	4284	0.887806454591625
R-HSA-389357	CD28 dependent PI3K/Akt signaling	 20	0.821370442274037	1	8	12	3930	4291	0.837074657186389
R-HSA-389359	CD28 dependent Vav1 pathway	 13	0.651619464532439	1	6	7	3932	4296	0.965855373676603
R-HSA-389513	CTLA4 inhibitory signaling	 21	0.0643726891781803	0.396062653800984	14	7	3924	4296	1.39512442864398
R-HSA-389599	Alpha-oxidation of phytanate	  6	0.613910056647902	1	3	3	3935	4300	1.04634332148299
R-HSA-389661	Glyoxylate metabolism and glycine degradation	 24	0.652666486736953	1	11	13	3927	4290	0.959148044692737
R-HSA-389887	Beta-oxidation of pristanoyl-CoA	  7	0.451634376327358	0.918433256168249	4	3	3934	4300	1.1958209388377
R-HSA-389948	PD-1 signaling	 16	0.983434150098479	1	4	12	3934	4291	0.523171660741493
R-HSA-389957	Prefoldin mediated transfer of substrate  to CCT/TriC	 23	0.0708700783260921	0.416325844741537	15	8	3923	4295	1.36479563671694
R-HSA-389958	Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding	 26	0.207170658079939	0.686311928936054	15	11	3923	4292	1.20731921709575
R-HSA-389960	Formation of tubulin folding intermediates by CCT/TriC	 20	0.192001881713922	0.666494570255742	12	8	3926	4295	1.25561198577958
R-HSA-389977	Post-chaperonin tubulin folding pathway	 18	0.33517537546619	0.818236200316395	10	8	3928	4295	1.16260369053665
R-HSA-390247	Beta-oxidation of very long chain fatty acids	  9	0.700733355278605	1	4	5	3934	4298	0.930082952429321
R-HSA-390450	Folding of actin by CCT/TriC	  9	0.0140341047943077	0.190312953799443	8	1	3930	4302	1.86016590485864
R-HSA-390466	Chaperonin-mediated protein folding	 77	0.267400373788297	0.772928726676344	40	37	3898	4266	1.08710994439791
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	 33	0.2725824910408	0.772928726676344	18	15	3920	4288	1.1414654416178
R-HSA-390522	Striated Muscle Contraction	 27	0.956787270479453	1	9	18	3929	4285	0.697562214321991
R-HSA-390666	Serotonin receptors	  9	0.997126674022736	1	1	8	3937	4295	0.23252073810733
R-HSA-390696	Adrenoceptors	  9	1	1	0	9	3938	4294	0
R-HSA-3906995	Diseases associated with O-glycosylation of proteins	 53	0.99315074256339	1	17	36	3921	4267	0.671239111894746
R-HSA-390918	Peroxisomal lipid metabolism	 25	0.717893653067638	1	11	14	3927	4289	0.920782122905028
R-HSA-391160	Signal regulatory protein family interactions	 13	0.435263368689903	0.918433256168249	7	6	3931	4297	1.12683126928937
R-HSA-391251	Protein folding	 83	0.142659959328249	0.568680222487058	45	38	3893	4265	1.13458914377673
R-HSA-391903	Eicosanoid ligand-binding receptors	 12	0.972463885279028	1	3	9	3935	4294	0.523171660741493
R-HSA-391908	Prostanoid ligand receptors	  9	0.97341621551606	1	2	7	3936	4296	0.465041476214661
R-HSA-392154	Nitric oxide stimulates guanylate cyclase	 23	0.732261729866932	1	10	13	3928	4290	0.909863757811292
R-HSA-392170	ADP signalling through P2Y purinoceptor 12	 17	0.426382730531353	0.918433256168249	9	8	3929	4295	1.10789292862904
R-HSA-392451	G beta:gamma signalling through PI3Kgamma	 39	0.843223935838796	1	16	23	3922	4280	0.858538109934758
R-HSA-392517	Rap1 signalling	 14	0.538655708122675	0.996925296538267	7	7	3931	4296	1.04634332148299
R-HSA-392518	Signal amplification	 27	0.560353574490703	1	13	14	3925	4289	1.00758986513176
R-HSA-392851	Prostacyclin signalling through prostacyclin receptor	 15	0.245416458813117	0.751264307463782	9	6	3929	4297	1.25561198577958
R-HSA-3928662	EPHB-mediated forward signaling	 40	0.0210705261524819	0.22480392240626	26	14	3912	4289	1.36024631792788
R-HSA-3928663	EPHA-mediated growth cone collapse	 26	0.939931574999271	1	9	17	3929	4286	0.724391530257452
R-HSA-3928664	Ephrin signaling	 19	0.603320340828141	1	9	10	3929	4293	0.991272620352303
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	 48	0.0283913002971895	0.266975277545073	30	18	3908	4285	1.30792915185373
R-HSA-397795	G-protein beta:gamma signalling	 42	0.865751211703737	1	17	25	3921	4278	0.847039831676703
R-HSA-399719	Trafficking of AMPA receptors	 30	0.00119013691942323	0.0431722167520777	23	7	3915	4296	1.60439309294058
R-HSA-399721	Glutamate binding, activation of AMPA receptors and synaptic plasticity	 30	0.00119013691942323	0.0431722167520777	23	7	3915	4296	1.60439309294058
R-HSA-399954	Sema3A PAK dependent Axon repulsion	 15	0.113632089157941	0.530161290572901	10	5	3928	4298	1.39512442864398
R-HSA-399955	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	 13	0.435263368689903	0.918433256168249	7	6	3931	4297	1.12683126928937
R-HSA-399956	CRMPs in Sema3A signaling	 15	0.430676252621717	0.918433256168249	8	7	3930	4296	1.11609954291519
R-HSA-399997	Acetylcholine regulates insulin secretion	 10	0.323700113595242	0.818236200316395	6	4	3932	4299	1.25561198577958
R-HSA-400042	Adrenaline,noradrenaline inhibits insulin secretion	 24	0.202901000970507	0.678362563152547	14	10	3924	4293	1.22073387506348
R-HSA-400253	Circadian Clock	 65	0.359409413009396	0.866284149961185	33	32	3905	4271	1.06244091104426
R-HSA-400451	Free fatty acids regulate insulin secretion	  7	0.73561681688831	1	3	4	3935	4299	0.896865704128274
R-HSA-400508	Incretin synthesis, secretion, and inactivation	 13	0.0325091832282712	0.284161595567599	10	3	3928	4300	1.60975895612767
R-HSA-400511	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	  8	0.0264284361188029	0.255651072055887	7	1	3931	4302	1.83110081259523
R-HSA-400685	Sema4D in semaphorin signaling	 24	0.652666486736953	1	11	13	3927	4290	0.959148044692737
R-HSA-4085001	Sialic acid metabolism	 30	0.748425391466277	1	13	17	3925	4286	0.906830878618588
R-HSA-4086398	Ca2+ pathway	 56	0.0616271630868096	0.395668201942304	33	23	3905	4280	1.23319034317638
R-HSA-4086400	PCP/CE pathway	 81	0.265944186293355	0.772928726676344	42	39	3896	4264	1.08509677783421
R-HSA-416482	G alpha (12/13) signalling events	 74	0.394534801131575	0.918433256168249	37	37	3901	4266	1.04634332148299
R-HSA-416550	Sema4D mediated inhibition of cell attachment and migration	  8	0.31592015436873	0.818236200316395	5	3	3933	4300	1.30792915185373
R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	 21	0.590936188394649	1	10	11	3928	4292	0.996517449031415
R-HSA-416700	Other semaphorin interactions	 15	0.430676252621717	0.918433256168249	8	7	3930	4296	1.11609954291519
R-HSA-416993	Trafficking of GluR2-containing AMPA receptors	 16	0.00118469047732047	0.0431722167520777	14	2	3924	4301	1.83110081259523
R-HSA-417957	P2Y receptors	  9	0.97341621551606	1	2	7	3936	4296	0.465041476214661
R-HSA-418038	Nucleotide-like (purinergic) receptors	 12	0.972463885279028	1	3	9	3935	4294	0.523171660741493
R-HSA-418217	G beta:gamma signalling through PLC beta	 16	0.33392496716077	0.818236200316395	9	7	3929	4296	1.17713623666836
R-HSA-418346	Platelet homeostasis	 79	0.432090387809866	0.918433256168249	39	40	3899	4263	1.03309846931232
R-HSA-418359	Reduction of cytosolic Ca++ levels	 12	0.760692490142898	1	5	7	3933	4296	0.871952767902489
R-HSA-418360	Platelet calcium homeostasis	 25	0.836596689554531	1	10	15	3928	4288	0.837074657186389
R-HSA-418457	cGMP effects	 17	0.899918550187916	1	6	11	3932	4292	0.738595285752696
R-HSA-418592	ADP signalling through P2Y purinoceptor 1	 21	0.418494363546959	0.918433256168249	11	10	3927	4293	1.09616919393456
R-HSA-418597	G alpha (z) signalling events	 41	0.833683142074716	1	17	24	3921	4279	0.867699339766379
R-HSA-418885	DCC mediated attractive signaling	 14	0.065444021370581	0.396062653800984	10	4	3928	4299	1.49477617354712
R-HSA-418886	Netrin mediated repulsion signals	 10	0.323700113595242	0.818236200316395	6	4	3932	4299	1.25561198577958
R-HSA-418889	Ligand-independent caspase activation via DCC	 10	0.567535190495185	1	5	5	3933	4298	1.04634332148299
R-HSA-418890	Role of second messengers in netrin-1 signaling	  7	0.451634376327358	0.918433256168249	4	3	3934	4300	1.1958209388377
R-HSA-418990	Adherens junctions interactions	 30	0.920870151787637	1	11	19	3927	4284	0.76731843575419
R-HSA-419037	NCAM1 interactions	 38	0.583782393851712	1	18	20	3920	4283	0.991272620352303
R-HSA-419408	Lysosphingolipid and LPA receptors	 12	0.972463885279028	1	3	9	3935	4294	0.523171660741493
R-HSA-419812	Calcitonin-like ligand receptors	  8	0.994492178633106	1	1	7	3937	4296	0.261585830370747
R-HSA-420029	Tight junction interactions	 21	0.998576406920156	1	4	17	3934	4286	0.398606979612566
R-HSA-420092	Glucagon-type ligand receptors	 24	0.652666486736953	1	11	13	3927	4290	0.959148044692737
R-HSA-420499	Class C/3 (Metabotropic glutamate/pheromone receptors)	 17	0.61724514479494	1	8	9	3930	4294	0.984793714336928
R-HSA-420597	Nectin/Necl  trans heterodimerization	  7	0.73561681688831	1	3	4	3935	4299	0.896865704128274
R-HSA-421270	Cell-cell junction organization	 53	0.998831615845753	1	15	38	3923	4265	0.592269804613011
R-HSA-421837	Clathrin derived vesicle budding	 63	0.000115275989746125	0.0128665739324329	45	18	3893	4285	1.49477617354712
R-HSA-422085	Synthesis, secretion, and deacylation of Ghrelin	 14	0.065444021370581	0.396062653800984	10	4	3928	4299	1.49477617354712
R-HSA-422356	Regulation of insulin secretion	 73	0.0596993427337583	0.386713153154836	42	31	3896	4272	1.2040114932133
R-HSA-425366	Transport of bile salts and organic acids, metal ions and amine compounds	 70	0.828650851101105	1	30	40	3908	4263	0.896865704128274
R-HSA-425381	Bicarbonate transporters	  7	0.73561681688831	1	3	4	3935	4299	0.896865704128274
R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	 91	0.930212343002444	1	37	54	3901	4249	0.850872591096055
R-HSA-425397	Transport of vitamins, nucleosides, and related molecules	 31	0.543786508967524	1	15	16	3923	4287	1.01259031111257
R-HSA-425410	Metal ion SLC transporters	 24	0.336011657617902	0.818236200316395	13	11	3925	4292	1.13353859827324
R-HSA-425561	Sodium/Calcium exchangers	 10	0.928057578421412	1	3	7	3935	4296	0.627805992889792
R-HSA-425986	Sodium/Proton exchangers	  8	0.824577748049705	1	3	5	3935	4298	0.78475749111224
R-HSA-426048	Arachidonate production from DAG	  5	0.458521658108405	0.918433256168249	3	2	3935	4301	1.25561198577958
R-HSA-426117	Cation-coupled Chloride cotransporters	  6	0.613910056647902	1	3	3	3935	4300	1.04634332148299
R-HSA-426486	Small interfering RNA (siRNA) biogenesis	  9	0.0140341047943077	0.190312953799443	8	1	3930	4302	1.86016590485864
R-HSA-426496	Post-transcriptional silencing by small RNAs	  7	0.00567362124891729	0.116811460860542	7	0	3931	4303	2.09268664296597
R-HSA-427359	SIRT1 negatively regulates rRNA expression	 27	0.994288477244852	1	7	20	3931	4283	0.542548388917104
R-HSA-427389	ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression	 35	0.983752209413205	1	11	24	3927	4279	0.657701516360734
R-HSA-427413	NoRC negatively regulates rRNA expression	 61	0.463342307111921	0.924772610205498	30	31	3908	4272	1.02919015227835
R-HSA-427601	Multifunctional anion exchangers	  8	0.824577748049705	1	3	5	3935	4298	0.78475749111224
R-HSA-428157	Sphingolipid metabolism	 80	0.650625421074852	1	37	43	3901	4260	0.967867572371762
R-HSA-428540	Activation of RAC1	 13	0.10148038410252	0.49578463748403	9	4	3929	4299	1.4487830605149
R-HSA-428542	Regulation of commissural axon pathfinding by SLIT and ROBO	 10	0.567535190495185	1	5	5	3933	4298	1.04634332148299
R-HSA-428543	Inactivation of CDC42 and RAC1	  7	0.0491362727338201	0.334726440078746	6	1	3932	4302	1.79373140825655
R-HSA-428643	Organic anion transporters	  9	0.886499944435254	1	3	6	3935	4297	0.697562214321991
R-HSA-428890	Role of ABL in ROBO-SLIT signaling	  8	0.117259782578872	0.535576201184411	6	2	3932	4301	1.56951498222448
R-HSA-428930	Thromboxane signalling through TP receptor	 19	0.256732391580523	0.772860373824353	11	8	3927	4295	1.21155542487504
R-HSA-429914	Deadenylation-dependent mRNA decay	 50	0.015160696057578	0.197568507635796	32	18	3906	4285	1.33931945149822
R-HSA-429947	Deadenylation of mRNA	 21	0.260713909784619	0.772928726676344	12	9	3926	4294	1.1958209388377
R-HSA-429958	mRNA decay by 3' to 5' exoribonuclease	 16	0.0256611463631857	0.255081422358691	12	4	3926	4299	1.56951498222448
R-HSA-430039	mRNA decay by 5' to 3' exoribonuclease	 13	0.237285205121634	0.72945091659214	8	5	3930	4298	1.28780716490214
R-HSA-430116	GP1b-IX-V activation signalling	  9	0.700733355278605	1	4	5	3934	4298	0.930082952429321
R-HSA-432040	Vasopressin regulates renal water homeostasis via Aquaporins	 38	0.806263049242858	1	16	22	3922	4281	0.881131218090936
R-HSA-432047	Passive transport by Aquaporins	  9	0.997126674022736	1	1	8	3937	4295	0.23252073810733
R-HSA-432142	Platelet sensitization by LDL	 16	0.0758654379270744	0.433388781229074	11	5	3927	4298	1.43872206703911
R-HSA-432720	Lysosome Vesicle Biogenesis	 29	0.0173140778925548	0.211115353126865	20	9	3918	4294	1.44323216756274
R-HSA-432722	Golgi Associated Vesicle Biogenesis	 48	0.00263667833369431	0.0721852879658573	33	15	3905	4288	1.43872206703911
R-HSA-434316	Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion	  7	0.73561681688831	1	3	4	3935	4299	0.896865704128274
R-HSA-435354	Zinc transporters	 15	0.245416458813117	0.751264307463782	9	6	3929	4297	1.25561198577958
R-HSA-435368	Zinc efflux and compartmentalization by the SLC30 family	  7	0.451634376327358	0.918433256168249	4	3	3934	4300	1.1958209388377
R-HSA-437239	Recycling pathway of L1	 40	0.0819446300132358	0.455885631712684	24	16	3914	4287	1.25561198577958
R-HSA-438064	Post NMDA receptor activation events	 33	0.0962569752558463	0.488352696140675	20	13	3918	4290	1.26829493513089
R-HSA-438066	Unblocking of NMDA receptor, glutamate binding and activation	 15	0.430676252621717	0.918433256168249	8	7	3930	4296	1.11609954291519
R-HSA-4411364	Binding of TCF/LEF:CTNNB1 to target gene promoters	  8	0.587348598285987	1	4	4	3934	4299	1.04634332148299
R-HSA-4419969	Depolymerisation of the Nuclear Lamina	 14	0.880263602988144	1	5	9	3933	4294	0.747388086773562
R-HSA-4420097	VEGFA-VEGFR2 Pathway	 94	0.451380025597959	0.918433256168249	46	48	3892	4255	1.02408069762165
R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	 20	0.680637955746851	1	9	11	3929	4292	0.941708989334688
R-HSA-442380	Zinc influx into cells by the SLC39 gene family	  8	0.31592015436873	0.818236200316395	5	3	3933	4300	1.30792915185373
R-HSA-442660	Na+/Cl- dependent neurotransmitter transporters	 15	0.633137731686013	1	7	8	3931	4295	0.976587100050787
R-HSA-442720	CREB phosphorylation through the activation of Adenylate Cyclase	  7	0.73561681688831	1	3	4	3935	4299	0.896865704128274
R-HSA-442729	CREB phosphorylation through the activation of CaMKII	 13	0.237285205121634	0.72945091659214	8	5	3930	4298	1.28780716490214
R-HSA-442742	CREB phosphorylation through the activation of Ras	 25	0.0768368207176038	0.434106091253944	16	9	3922	4294	1.33931945149822
R-HSA-442755	Activation of NMDA receptor and postsynaptic events	 37	0.103829666952241	0.503869052667898	22	15	3916	4288	1.24430016608788
R-HSA-442982	Ras activation uopn Ca2+ infux through NMDA receptor	 15	0.113632089157941	0.530161290572901	10	5	3928	4298	1.39512442864398
R-HSA-444257	RSK activation	  6	0.613910056647902	1	3	3	3935	4300	1.04634332148299
R-HSA-444473	Formyl peptide receptors bind formyl peptides and many other ligands	  6	0.86854805730333	1	2	4	3936	4299	0.697562214321991
R-HSA-445095	Interaction between L1 and Ankyrins	 28	0.210834043367485	0.693349749293164	16	12	3922	4291	1.1958209388377
R-HSA-445144	Signal transduction by L1	 18	0.517590085596515	0.97535482363707	9	9	3929	4294	1.04634332148299
R-HSA-445355	Smooth Muscle Contraction	 32	0.609290931330866	1	15	17	3923	4286	0.9809468638903
R-HSA-445717	Aquaporin-mediated transport	 43	0.8927801292953	1	17	26	3921	4277	0.827341230940036
R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	 29	0.551766837618177	1	14	15	3924	4288	1.01026251729392
R-HSA-446107	Type I hemidesmosome assembly	  9	0.97341621551606	1	2	7	3936	4296	0.465041476214661
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	 70	0.828650851101105	1	30	40	3908	4263	0.896865704128274
R-HSA-446199	Synthesis of Dolichyl-phosphate	  5	0.458521658108405	0.918433256168249	3	2	3935	4301	1.25561198577958
R-HSA-446210	Synthesis of UDP-N-acetyl-glucosamine	  8	0.954101488609214	1	2	6	3936	4297	0.523171660741493
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	 58	0.719926028840165	1	26	32	3912	4271	0.938100908915781
R-HSA-446353	Cell-extracellular matrix interactions	 16	0.715356771155285	1	7	9	3931	4294	0.915550406297613
R-HSA-446388	Regulation of cytoskeletal remodeling and cell spreading by IPP complex components	  7	0.73561681688831	1	3	4	3935	4299	0.896865704128274
R-HSA-446728	Cell junction organization	 76	0.999749153273155	1	22	54	3916	4249	0.605777712437518
R-HSA-447038	NrCAM interactions	  7	0.191757422000069	0.666494570255742	5	2	3933	4301	1.49477617354712
R-HSA-447041	CHL1 interactions	  5	0.78366872375152	1	2	3	3936	4300	0.837074657186389
R-HSA-447043	Neurofascin interactions	  7	0.0491362727338201	0.334726440078746	6	1	3932	4302	1.79373140825655
R-HSA-447115	Interleukin-12 family signaling	 42	0.225749532827633	0.719491146466787	23	19	3915	4284	1.14599506638613
R-HSA-448424	Interleukin-17 signaling	 67	0.135447394299038	0.566564079971367	37	30	3901	4273	1.15566277298121
R-HSA-448706	Interleukin-1 processing	  5	1	1	0	5	3938	4298	0
R-HSA-449836	Other interleukin signaling	 21	0.747914281261003	1	9	12	3929	4291	0.896865704128274
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	 31	0.045355813748229	0.334726440078746	20	11	3918	4292	1.35012041481676
R-HSA-450294	MAP kinase activation in TLR cascade	 60	0.0381567974842827	0.316374360855395	36	24	3902	4279	1.25561198577958
R-HSA-450302	activated TAK1 mediates p38 MAPK activation	 20	0.508821033705273	0.970935078787117	10	10	3928	4293	1.04634332148299
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	 19	0.256732391580523	0.772860373824353	11	8	3927	4295	1.21155542487504
R-HSA-450341	Activation of the AP-1 family of transcription factors	 10	0.323700113595242	0.818236200316395	6	4	3932	4299	1.25561198577958
R-HSA-450385	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	 17	0.12396186136289	0.551744358397404	11	6	3927	4297	1.35409135721328
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	 45	0.499531803565555	0.96514067506474	22	23	3916	4280	1.02309124767225
R-HSA-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	 17	0.12396186136289	0.551744358397404	11	6	3927	4297	1.35409135721328
R-HSA-450520	HuR (ELAVL1) binds and stabilizes mRNA	  7	0.191757422000069	0.666494570255742	5	2	3933	4301	1.49477617354712
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	 76	0.0768885358044545	0.434106091253944	43	33	3895	4270	1.1840200743097
R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA	 17	0.0156736968712207	0.197568507635796	13	4	3925	4299	1.60028978579751
R-HSA-451306	Ionotropic activity of kainate receptors	 10	0.323700113595242	0.818236200316395	6	4	3932	4299	1.25561198577958
R-HSA-451308	Activation of Ca-permeable Kainate Receptor	 10	0.323700113595242	0.818236200316395	6	4	3932	4299	1.25561198577958
R-HSA-451326	Activation of kainate receptors upon glutamate binding	 26	0.207170658079939	0.686311928936054	15	11	3923	4292	1.20731921709575
R-HSA-451927	Interleukin-2 family signaling	 32	0.838805425032378	1	13	19	3925	4284	0.850153948704926
R-HSA-452723	Transcriptional regulation of pluripotent stem cells	 31	0.271541935044563	0.772928726676344	17	14	3921	4289	1.14760235259424
R-HSA-453276	Regulation of mitotic cell cycle	 72	0.397165941731567	0.918433256168249	36	36	3902	4267	1.04634332148299
R-HSA-4551638	SUMOylation of chromatin organization proteins	 55	0.0787691121767447	0.442999929335103	32	23	3906	4280	1.21756313772566
R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs)	 26	0.335682325220151	0.818236200316395	14	12	3924	4291	1.12683126928937
R-HSA-4570464	SUMOylation of RNA binding proteins	 41	0.181017333324314	0.655002869460297	23	18	3915	4285	1.17394616556628
R-HSA-4608870	Asymmetric localization of PCP proteins	 54	0.638412132615815	1	25	29	3913	4274	0.968836408780543
R-HSA-4615885	SUMOylation of DNA replication proteins	 42	0.328514793198332	0.818236200316395	22	20	3916	4283	1.09616919393456
R-HSA-4641257	Degradation of AXIN	 46	0.438258935375067	0.918433256168249	23	23	3915	4280	1.04634332148299
R-HSA-4641258	Degradation of DVL	 48	0.549472819918126	1	23	25	3915	4278	1.00274568308786
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	 29	0.270218320456128	0.772928726676344	16	13	3922	4290	1.15458573405019
R-HSA-4641263	Regulation of FZD by ubiquitination	 18	0.69696919215368	1	8	10	3930	4293	0.930082952429321
R-HSA-4641265	Repression of WNT target genes	 14	0.736342281839761	1	6	8	3932	4295	0.896865704128274
R-HSA-4791275	Signaling by WNT in cancer	 30	0.123274361230653	0.551744358397404	18	12	3920	4291	1.25561198577958
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	 14	0.065444021370581	0.396062653800984	10	4	3928	4299	1.49477617354712
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	 15	0.0413499874769008	0.32057602598237	11	4	3927	4299	1.53463687150838
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	 14	0.065444021370581	0.396062653800984	10	4	3928	4299	1.49477617354712
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	 14	0.065444021370581	0.396062653800984	10	4	3928	4299	1.49477617354712
R-HSA-499943	Interconversion of nucleotide di- and triphosphates	 26	0.640506040097296	1	12	14	3926	4289	0.965855373676603
R-HSA-500657	Presynaptic function of Kainate receptors	 17	0.426382730531353	0.918433256168249	9	8	3929	4295	1.10789292862904
R-HSA-5083625	Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)	 11	1	1	0	11	3938	4292	0
R-HSA-5083630	Defective LFNG causes SCDO3	  5	0.78366872375152	1	2	3	3936	4300	0.837074657186389
R-HSA-5083632	Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)	 11	1	1	0	11	3938	4292	0
R-HSA-5083635	Defective B3GALTL causes Peters-plus syndrome (PpS)	 30	0.920870151787637	1	11	19	3927	4284	0.76731843575419
R-HSA-5083636	Defective GALNT12 causes colorectal cancer 1 (CRCS1)	 11	0.999218282446089	1	1	10	3937	4293	0.190244240269634
R-HSA-5099900	WNT5A-dependent internalization of FZD4	 15	0.0113298881511459	0.173049133761186	12	3	3926	4300	1.67414931437278
R-HSA-512988	Interleukin-3, 5 and GM-CSF signaling	 42	0.685692944056181	1	19	23	3919	4280	0.946691576579845
R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	 12	0.0537310911895786	0.355999147562002	9	3	3929	4300	1.56951498222448
R-HSA-5173105	O-linked glycosylation	 95	0.996407194573697	1	33	62	3905	4241	0.726933254925022
R-HSA-5173214	O-glycosylation of TSR domain-containing proteins	 31	0.884162955739711	1	12	19	3926	4284	0.810072248890054
R-HSA-5205647	Mitophagy	 24	0.0062357078090248	0.12566683376243	18	6	3920	4297	1.56951498222448
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	 18	0.00211995731750615	0.0637901629168669	15	3	3923	4300	1.74390553580498
R-HSA-5210891	Uptake and function of anthrax toxins	 11	0.226607480313798	0.719491146466787	7	4	3931	4299	1.33170968188744
R-HSA-5213460	RIPK1-mediated regulated necrosis	 19	0.952006368458804	1	6	13	3932	4290	0.660848413568202
R-HSA-5218859	Regulated Necrosis	 19	0.952006368458804	1	6	13	3932	4290	0.660848413568202
R-HSA-5218900	CASP8 activity is inhibited	 11	0.991330455518455	1	2	9	3936	4294	0.380488480539268
R-HSA-5218920	VEGFR2 mediated vascular permeability	 27	0.560353574490703	1	13	14	3925	4289	1.00758986513176
R-HSA-5218921	VEGFR2 mediated cell proliferation	 19	0.422334246450265	0.918433256168249	10	9	3928	4294	1.10141402261367
R-HSA-5223345	Miscellaneous transport and binding events	 22	0.100707670695172	0.49578463748403	14	8	3924	4295	1.33170968188744
R-HSA-5250913	Positive epigenetic regulation of rRNA expression	 63	0.56006400736025	1	30	33	3908	4270	0.996517449031416
R-HSA-5250924	B-WICH complex positively regulates rRNA expression	 48	0.660589354378698	1	22	26	3916	4277	0.959148044692737
R-HSA-5250941	Negative epigenetic regulation of rRNA expression	 64	0.507543640294326	0.970935078787117	31	33	3907	4270	1.01364509268664
R-HSA-5250955	Toxicity of botulinum toxin type D (BoNT/D)	  5	0.160967868205754	0.608240564496221	4	1	3934	4302	1.67414931437278
R-HSA-5250981	Toxicity of botulinum toxin type F (BoNT/F)	  5	0.160967868205754	0.608240564496221	4	1	3934	4302	1.67414931437278
R-HSA-525793	Myogenesis	 27	0.70462801258257	1	12	15	3926	4288	0.930082952429321
R-HSA-5260271	Diseases of Immune System	 23	0.990582476502306	1	6	17	3932	4286	0.545918254686775
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	 29	0.000109527755282376	0.0128665739324329	24	5	3914	4298	1.73187860107529
R-HSA-5334118	DNA methylation	 22	0.999148332909084	1	4	18	3934	4285	0.380488480539268
R-HSA-5336415	Uptake and function of diphtheria toxin	  6	0.303133259568907	0.818236200316395	4	2	3934	4301	1.39512442864398
R-HSA-5339562	Uptake and actions of bacterial toxins	 27	0.00500586666906221	0.105268297634917	20	7	3918	4296	1.55013825404887
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	 15	0.0413499874769008	0.32057602598237	11	4	3927	4299	1.53463687150838
R-HSA-5340588	RNF mutants show enhanced WNT signaling and proliferation	  6	0.979768658250007	1	1	5	3937	4298	0.348781107160995
R-HSA-5357769	Caspase activation via extrinsic apoptotic signalling pathway	 25	0.964324329850068	1	8	17	3930	4286	0.669659725749111
R-HSA-5357786	TNFR1-induced proapoptotic signaling	 13	0.936367727562474	1	4	9	3934	4294	0.643903582451068
R-HSA-5357905	Regulation of TNFR1 signaling	 29	0.404736326220633	0.918433256168249	15	14	3923	4289	1.08242412567205
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	 26	0.335682325220151	0.818236200316395	14	12	3924	4291	1.12683126928937
R-HSA-5358346	Hedgehog ligand biogenesis	 55	0.68458251044393	1	25	30	3913	4273	0.951221201348169
R-HSA-5358493	Synthesis of diphthamide-EEF2	  8	0.824577748049705	1	3	5	3935	4298	0.78475749111224
R-HSA-5358508	Mismatch Repair	 12	0.760692490142898	1	5	7	3933	4296	0.871952767902489
R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	 11	0.67363845463036	1	5	6	3933	4297	0.951221201348169
R-HSA-5358606	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	 11	0.67363845463036	1	5	6	3933	4297	0.951221201348169
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	 15	0.0413499874769008	0.32057602598237	11	4	3927	4299	1.53463687150838
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	 15	0.0413499874769008	0.32057602598237	11	4	3927	4299	1.53463687150838
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	 15	0.0413499874769008	0.32057602598237	11	4	3927	4299	1.53463687150838
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	 15	0.0413499874769008	0.32057602598237	11	4	3927	4299	1.53463687150838
R-HSA-5362517	Signaling by Retinoic Acid	 35	0.659992934165155	1	16	19	3922	4284	0.956656751070159
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	 46	0.326135313022753	0.818236200316395	24	22	3914	4281	1.09183650937355
R-HSA-5362798	Release of Hh-Np from the secreting cell	  8	0.994492178633106	1	1	7	3937	4296	0.261585830370747
R-HSA-5365859	RA biosynthesis pathway	 17	0.784034909607526	1	7	10	3931	4293	0.861694500044812
R-HSA-5368286	Mitochondrial translation initiation	 74	0.00878545691072232	0.151758309255453	46	28	3892	4275	1.30085926454642
R-HSA-5368287	Mitochondrial translation	 78	0.00260557532283418	0.0721852879658573	50	28	3888	4275	1.34146579677306
R-HSA-5368598	Negative regulation of TCF-dependent signaling by DVL-interacting proteins	  5	1	1	0	5	3938	4298	0
R-HSA-5387390	Hh mutants abrogate ligand secretion	 49	0.489435136250533	0.955814781560597	24	25	3914	4278	1.0249893761466
R-HSA-5389840	Mitochondrial translation elongation	 74	0.00219814482828625	0.0637901629168669	48	26	3890	4277	1.35741836300496
R-HSA-539107	Activation of E2F1 target genes at G1/S	 21	0.866574233666673	1	8	13	3930	4290	0.797213959225132
R-HSA-5419276	Mitochondrial translation termination	 74	0.00219814482828625	0.0637901629168669	48	26	3890	4277	1.35741836300496
R-HSA-5423646	Aflatoxin activation and detoxification	 16	0.983434150098479	1	4	12	3934	4291	0.523171660741493
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	 14	0.065444021370581	0.396062653800984	10	4	3928	4299	1.49477617354712
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	 14	0.065444021370581	0.396062653800984	10	4	3928	4299	1.49477617354712
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	 14	0.065444021370581	0.396062653800984	10	4	3928	4299	1.49477617354712
R-HSA-549127	Organic cation transport	  8	0.954101488609214	1	2	6	3936	4297	0.523171660741493
R-HSA-549132	Organic cation/anion/zwitterion transport	 12	0.99510376956634	1	2	10	3936	4293	0.348781107160995
R-HSA-5576886	Phase 4 - resting membrane potential	 16	0.996480257591012	1	3	13	3935	4290	0.39237874555612
R-HSA-5576890	Phase 3 - rapid repolarisation	  5	0.78366872375152	1	2	3	3936	4300	0.837074657186389
R-HSA-5576892	Phase 0 - rapid depolarisation	 38	0.222890968542683	0.717105976397856	21	17	3917	4286	1.15648472374435
R-HSA-5576893	Phase 2 - plateau phase	 21	0.418494363546959	0.918433256168249	11	10	3927	4293	1.09616919393456
R-HSA-5576894	Phase 1 - inactivation of fast Na+ channels	  7	0.451634376327358	0.918433256168249	4	3	3934	4300	1.1958209388377
R-HSA-5578749	Transcriptional regulation by small RNAs	 62	0.411264906359635	0.918433256168249	31	31	3907	4272	1.04634332148299
R-HSA-5578768	Physiological factors	  8	0.824577748049705	1	3	5	3935	4298	0.78475749111224
R-HSA-5578775	Ion homeostasis	 49	0.489435136250533	0.955814781560597	24	25	3914	4278	1.0249893761466
R-HSA-5579029	Metabolic disorders of biological oxidation enzymes	 23	0.579787672048245	1	11	12	3927	4291	1.00085013359242
R-HSA-5601884	PIWI-interacting RNA (piRNA) biogenesis	 23	0.0708700783260921	0.416325844741537	15	8	3923	4295	1.36479563671694
R-HSA-5602358	Diseases associated with the TLR signaling cascade	 23	0.990582476502306	1	6	17	3932	4286	0.545918254686775
R-HSA-5602498	MyD88 deficiency (TLR2/4)	 10	0.998501207270849	1	1	9	3937	4294	0.209268664296597
R-HSA-5603027	IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)	  7	0.73561681688831	1	3	4	3935	4299	0.896865704128274
R-HSA-5603029	IkBA variant leads to EDA-ID	  6	0.613910056647902	1	3	3	3935	4300	1.04634332148299
R-HSA-5603041	IRAK4 deficiency (TLR2/4)	 10	0.998501207270849	1	1	9	3937	4294	0.209268664296597
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	 53	0.589278237321428	1	25	28	3913	4275	0.987116341021685
R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation	 10	0.137803517982411	0.566564079971367	7	3	3931	4300	1.46488065007618
R-HSA-5607764	CLEC7A (Dectin-1) signaling	 87	0.505683023098481	0.970563580047481	42	45	3896	4258	1.01026251729392
R-HSA-5609975	Diseases associated with glycosylation precursor biosynthesis	 14	0.736342281839761	1	6	8	3932	4295	0.896865704128274
R-HSA-5610780	Degradation of GLI1 by the proteasome	 51	0.27442542500707	0.772928726676344	27	24	3911	4279	1.10789292862904
R-HSA-5610783	Degradation of GLI2 by the proteasome	 51	0.27442542500707	0.772928726676344	27	24	3911	4279	1.10789292862904
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	 51	0.374870899848496	0.902052530149532	26	25	3912	4278	1.06685985719834
R-HSA-5610787	Hedgehog 'off' state	 99	0.146629300366085	0.573853740440181	53	46	3885	4257	1.12032719269896
R-HSA-5617472	Activation of anterior HOX genes in hindbrain development during early embryogenesis	 69	0.799394318233717	1	30	39	3908	4264	0.909863757811292
R-HSA-5619084	ABC transporter disorders	 64	0.507543640294326	0.970935078787117	31	33	3907	4270	1.01364509268664
R-HSA-5619102	SLC transporter disorders	 47	0.49437775469763	0.959013532174145	23	24	3915	4279	1.02408069762165
R-HSA-5619507	Activation of HOX genes during differentiation	 69	0.799394318233717	1	30	39	3908	4264	0.909863757811292
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	 93	0.0104105596045786	0.16108520665347	56	37	3882	4266	1.26011238716231
R-HSA-5620916	VxPx cargo-targeting to cilium	 20	0.0933613259335015	0.478682982083076	13	7	3925	4296	1.36024631792788
R-HSA-5620920	Cargo trafficking to the periciliary membrane	 45	0.0178910023001968	0.214544168079219	29	16	3909	4287	1.34862028102252
R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	 19	0.132817548245669	0.566564079971367	12	7	3926	4296	1.3216968271364
R-HSA-5620924	Intraflagellar transport	 47	0.00386896329107224	0.0921358505185837	32	15	3906	4288	1.42480792712577
R-HSA-5621480	Dectin-2 family	 17	0.999739138400515	1	2	15	3936	4288	0.246198428584232
R-HSA-5621575	CD209 (DC-SIGN) signaling	 21	0.418494363546959	0.918433256168249	11	10	3927	4293	1.09616919393456
R-HSA-5625740	RHO GTPases activate PKNs	 50	0.966179336970532	1	18	32	3920	4271	0.75336719146775
R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	 26	0.999422241750242	1	5	21	3933	4282	0.402439739031918
R-HSA-5625900	RHO GTPases activate CIT	 15	0.633137731686013	1	7	8	3931	4295	0.976587100050787
R-HSA-5625970	RHO GTPases activate KTN1	 11	0.67363845463036	1	5	6	3933	4297	0.951221201348169
R-HSA-5626467	RHO GTPases activate IQGAPs	 23	0.0708700783260921	0.416325844741537	15	8	3923	4295	1.36479563671694
R-HSA-5626978	TNFR1-mediated ceramide production	  5	0.78366872375152	1	2	3	3936	4300	0.837074657186389
R-HSA-5627117	RHO GTPases Activate ROCKs	 16	0.715356771155285	1	7	9	3931	4294	0.915550406297613
R-HSA-5627123	RHO GTPases activate PAKs	 20	0.192001881713922	0.666494570255742	12	8	3926	4295	1.25561198577958
R-HSA-5628897	TP53 Regulates Metabolic Genes	 79	2.69874117028011e-07	0.000195793671903822	60	19	3878	4284	1.58938226048049
R-HSA-5632681	Ligand-receptor interactions	  7	0.921720553469337	1	2	5	3936	4298	0.597910469418849
R-HSA-5632684	Hedgehog 'on' state	 74	0.667611645847793	1	34	40	3904	4263	0.961504673795177
R-HSA-5633008	TP53 Regulates Transcription of Cell Death Genes	 42	0.958761138679262	1	15	27	3923	4276	0.747388086773562
R-HSA-5635838	Activation of SMO	 16	0.996480257591012	1	3	13	3935	4290	0.39237874555612
R-HSA-5635851	GLI proteins bind promoters of Hh responsive genes to promote transcription	  7	0.73561681688831	1	3	4	3935	4299	0.896865704128274
R-HSA-5637810	Constitutive Signaling by EGFRvIII	 14	0.0193352479713472	0.218236557583022	11	3	3927	4300	1.64425379090184
R-HSA-5637812	Signaling by EGFRvIII in Cancer	 14	0.0193352479713472	0.218236557583022	11	3	3927	4300	1.64425379090184
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	 17	0.0156736968712207	0.197568507635796	13	4	3925	4299	1.60028978579751
R-HSA-5649702	APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway	  7	0.0491362727338201	0.334726440078746	6	1	3932	4302	1.79373140825655
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	 19	0.256732391580523	0.772860373824353	11	8	3927	4295	1.21155542487504
R-HSA-5652084	Fructose metabolism	  6	0.979768658250007	1	1	5	3937	4298	0.348781107160995
R-HSA-5654219	Phospholipase C-mediated cascade: FGFR1	 13	0.997251230834039	1	2	11	3936	4292	0.321951791225534
R-HSA-5654221	Phospholipase C-mediated cascade; FGFR2	 13	0.997251230834039	1	2	11	3936	4292	0.321951791225534
R-HSA-5654227	Phospholipase C-mediated cascade; FGFR3	 11	0.991330455518455	1	2	9	3936	4294	0.380488480539268
R-HSA-5654228	Phospholipase C-mediated cascade; FGFR4	 11	0.999218282446089	1	1	10	3937	4293	0.190244240269634
R-HSA-5654687	Downstream signaling of activated FGFR1	 28	0.629311627077588	1	13	15	3925	4288	0.97160451280563
R-HSA-5654688	SHC-mediated cascade:FGFR1	 18	0.975838312435837	1	5	13	3933	4290	0.581301845268326
R-HSA-5654689	PI-3K cascade:FGFR1	 18	0.930157642197342	1	6	12	3932	4291	0.697562214321991
R-HSA-5654693	FRS-mediated FGFR1 signaling	 20	0.821370442274037	1	8	12	3930	4291	0.837074657186389
R-HSA-5654695	PI-3K cascade:FGFR2	 18	0.930157642197342	1	6	12	3932	4291	0.697562214321991
R-HSA-5654696	Downstream signaling of activated FGFR2	 25	0.717893653067638	1	11	14	3927	4289	0.920782122905028
R-HSA-5654699	SHC-mediated cascade:FGFR2	 18	0.975838312435837	1	5	13	3933	4290	0.581301845268326
R-HSA-5654700	FRS-mediated FGFR2 signaling	 20	0.821370442274037	1	8	12	3930	4291	0.837074657186389
R-HSA-5654704	SHC-mediated cascade:FGFR3	 16	0.944551976433802	1	5	11	3933	4292	0.653964575926866
R-HSA-5654706	FRS-mediated FGFR3 signaling	 18	0.69696919215368	1	8	10	3930	4293	0.930082952429321
R-HSA-5654708	Downstream signaling of activated FGFR3	 23	0.579787672048245	1	11	12	3927	4291	1.00085013359242
R-HSA-5654710	PI-3K cascade:FGFR3	 16	0.859018441747778	1	6	10	3932	4293	0.78475749111224
R-HSA-5654712	FRS-mediated FGFR4 signaling	 18	0.839440366169065	1	7	11	3931	4292	0.813822583375656
R-HSA-5654716	Downstream signaling of activated FGFR4	 23	0.732261729866932	1	10	13	3928	4290	0.909863757811292
R-HSA-5654719	SHC-mediated cascade:FGFR4	 16	0.983434150098479	1	4	12	3934	4291	0.523171660741493
R-HSA-5654720	PI-3K cascade:FGFR4	 16	0.944551976433802	1	5	11	3933	4292	0.653964575926866
R-HSA-5654726	Negative regulation of FGFR1 signaling	 29	0.692316768513358	1	13	16	3925	4287	0.938100908915781
R-HSA-5654727	Negative regulation of FGFR2 signaling	 28	0.629311627077588	1	13	15	3925	4288	0.97160451280563
R-HSA-5654732	Negative regulation of FGFR3 signaling	 26	0.486984821874362	0.954885103432026	13	13	3925	4290	1.04634332148299
R-HSA-5654733	Negative regulation of FGFR4 signaling	 26	0.640506040097296	1	12	14	3926	4289	0.965855373676603
R-HSA-5654736	Signaling by FGFR1	 46	0.438258935375067	0.918433256168249	23	23	3915	4280	1.04634332148299
R-HSA-5654738	Signaling by FGFR2	 63	0.0859788250732974	0.464288021493932	36	27	3902	4276	1.1958209388377
R-HSA-5654741	Signaling by FGFR3	 37	0.273983557677975	0.772928726676344	20	17	3918	4286	1.1311819691708
R-HSA-5654743	Signaling by FGFR4	 36	0.331798030656594	0.818236200316395	19	17	3919	4286	1.10447350600982
R-HSA-5655253	Signaling by FGFR2 in disease	 36	0.459533110942901	0.918433256168249	18	18	3920	4285	1.04634332148299
R-HSA-5655291	Signaling by FGFR4 in disease	 11	0.087058396650189	0.464288021493932	8	3	3930	4300	1.52195392215707
R-HSA-5655302	Signaling by FGFR1 in disease	 36	0.331798030656594	0.818236200316395	19	17	3919	4286	1.10447350600982
R-HSA-5655332	Signaling by FGFR3 in disease	 20	0.680637955746851	1	9	11	3929	4292	0.941708989334688
R-HSA-5655862	Translesion synthesis by POLK	 16	0.0758654379270744	0.433388781229074	11	5	3927	4298	1.43872206703911
R-HSA-5656121	Translesion synthesis by POLI	 16	0.0758654379270744	0.433388781229074	11	5	3927	4298	1.43872206703911
R-HSA-5656169	Termination of translesion DNA synthesis	 28	0.480786590736604	0.944007230255498	14	14	3924	4289	1.04634332148299
R-HSA-5658442	Regulation of RAS by GAPs	 58	0.231191176061946	0.720590664097588	31	27	3907	4276	1.11850492986112
R-HSA-5658623	FGFRL1 modulation of FGFR1 signaling	 11	0.999218282446089	1	1	10	3937	4293	0.190244240269634
R-HSA-5660526	Response to metal ions	 10	0.789532131800886	1	4	6	3934	4297	0.837074657186389
R-HSA-5660668	CLEC7A/inflammasome pathway	  5	0.961231891425561	1	1	4	3937	4299	0.418537328593195
R-HSA-5661231	Metallothioneins bind metals	  7	0.921720553469337	1	2	5	3936	4298	0.597910469418849
R-HSA-5663084	Diseases of carbohydrate metabolism	 29	0.949005170917345	1	10	19	3928	4284	0.72161608378137
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	 34	0.131542826083727	0.566564079971367	20	14	3918	4289	1.23099214292116
R-HSA-5666185	RHO GTPases Activate Rhotekin and Rhophilins	  8	0.31592015436873	0.818236200316395	5	3	3933	4300	1.30792915185373
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	 79	0.969698525475917	1	30	49	3908	4254	0.794691130240243
R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	 11	0.991330455518455	1	2	9	3936	4294	0.380488480539268
R-HSA-5668914	Diseases of metabolism	 82	0.559721873816428	1	39	43	3899	4260	0.99530218384967
R-HSA-5669034	TNFs bind their physiological receptors	 17	0.997938385280364	1	3	14	3935	4289	0.369297642876348
R-HSA-5673000	RAF activation	 25	0.0123715976188282	0.181325132776967	18	7	3920	4296	1.5067343829355
R-HSA-5674135	MAP2K and MAPK activation	 37	0.522730819288151	0.983764486105198	18	19	3920	4284	1.01806377225372
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	 24	0.202901000970507	0.678362563152547	14	10	3924	4293	1.22073387506348
R-HSA-5674499	Negative feedback regulation of MAPK pathway	  6	0.303133259568907	0.818236200316395	4	2	3934	4301	1.39512442864398
R-HSA-5675221	Negative regulation of MAPK pathway	 38	0.00308152090696503	0.0812961242910228	27	11	3911	4292	1.48690893052845
R-HSA-5675482	Regulation of necroptotic cell death	 17	0.899918550187916	1	6	11	3932	4292	0.738595285752696
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	 50	0.430854971423198	0.918433256168249	25	25	3913	4278	1.04634332148299
R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	 15	0.999146406654606	1	2	13	3936	4290	0.279024885728796
R-HSA-5676934	Protein repair	  6	0.613910056647902	1	3	3	3935	4300	1.04634332148299
R-HSA-5678895	Defective CFTR causes cystic fibrosis	 50	0.430854971423198	0.918433256168249	25	25	3913	4278	1.04634332148299
R-HSA-5682910	LGI-ADAM interactions	 14	0.166345837020011	0.618228588257232	9	5	3929	4298	1.34529855619241
R-HSA-5683826	Surfactant metabolism	 20	0.915906277694761	1	7	13	3931	4290	0.73244032503809
R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	 14	0.166345837020011	0.618228588257232	9	5	3929	4298	1.34529855619241
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	 29	0.00193965613353922	0.0625431344392312	22	7	3916	4296	1.58755538431901
R-HSA-5685939	HDR through MMEJ (alt-NHEJ)	  8	0.31592015436873	0.818236200316395	5	3	3933	4300	1.30792915185373
R-HSA-5685942	HDR through Homologous Recombination (HRR)	 49	0.0208484028558549	0.22480392240626	31	18	3907	4285	1.32394461085602
R-HSA-5686938	Regulation of TLR by endogenous ligand	 16	0.999527285092262	1	2	14	3936	4289	0.261585830370747
R-HSA-5687128	MAPK6/MAPK4 signaling	 78	0.0498613815402057	0.336506347045761	45	33	3893	4270	1.20731921709575
R-HSA-5687613	Diseases associated with surfactant metabolism	  8	0.587348598285987	1	4	4	3934	4299	1.04634332148299
R-HSA-5688849	Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)	  5	0.961231891425561	1	1	4	3937	4299	0.418537328593195
R-HSA-5688890	Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)	  5	0.961231891425561	1	1	4	3937	4299	0.418537328593195
R-HSA-5689603	UCH proteinases	 77	0.197800665942672	0.669358877079889	41	36	3897	4267	1.11428769300786
R-HSA-5689877	Josephin domain DUBs	 10	0.137803517982411	0.566564079971367	7	3	3931	4300	1.46488065007618
R-HSA-5689896	Ovarian tumor domain proteases	 35	0.659992934165155	1	16	19	3922	4284	0.956656751070159
R-HSA-5689901	Metalloprotease DUBs	 21	0.260713909784619	0.772928726676344	12	9	3926	4294	1.1958209388377
R-HSA-5690714	CD22 mediated BCR regulation	 15	0.99994221717738	1	1	14	3937	4289	0.139512442864398
R-HSA-5693537	Resolution of D-Loop Structures	 23	0.147121703269295	0.573853740440181	14	9	3924	4294	1.27380926093581
R-HSA-5693538	Homology Directed Repair	 96	0.17085016519319	0.62760402454511	51	45	3887	4258	1.11173977907567
R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	 18	0.184992219123502	0.666063796397523	11	7	3927	4296	1.27886405959032
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	 50	0.652905327135026	1	23	27	3915	4276	0.962635855764347
R-HSA-5693567	HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)	 90	0.229172889117781	0.719761606298485	47	43	3891	4260	1.09284746910445
R-HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	 23	0.147121703269295	0.573853740440181	14	9	3924	4294	1.27380926093581
R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	 43	0.504918088750334	0.970379002353292	21	22	3917	4281	1.0220097558671
R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	 31	0.0025306179399193	0.0719985613886843	23	8	3915	4295	1.55263847703927
R-HSA-5693606	DNA Double Strand Break Response	 50	0.652905327135026	1	23	27	3915	4276	0.962635855764347
R-HSA-5693607	Processing of DNA double-strand break ends	 65	0.271327209179372	0.772928726676344	34	31	3904	4272	1.09463609016682
R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	 29	0.000506915959814717	0.0262691092032555	23	6	3915	4297	1.65971699269715
R-HSA-5694530	Cargo concentration in the ER	 29	0.162584318232962	0.612752846119553	17	12	3921	4291	1.22674734242833
R-HSA-5696394	DNA Damage Recognition in GG-NER	 36	0.0172534554599665	0.211115353126865	24	12	3914	4291	1.39512442864398
R-HSA-5696395	Formation of Incision Complex in GG-NER	 37	0.00163139312360652	0.0563607481512634	27	10	3911	4293	1.52709565838057
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	 22	0.336091506125825	0.818236200316395	12	10	3926	4293	1.1414654416178
R-HSA-5696398	Nucleotide Excision Repair	 97	4.03066498784469e-05	0.00731061862170331	66	31	3872	4272	1.42388988078097
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	 75	0.000713393353214156	0.0333914114681852	50	25	3888	4278	1.39512442864398
R-HSA-5696400	Dual Incision in GG-NER	 35	0.0104288140672497	0.16108520665347	24	11	3914	4292	1.43498512660524
R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere	 36	0.999599923160969	1	8	28	3930	4275	0.465041476214661
R-HSA-611105	Respiratory electron transport	 76	3.5901617840647e-06	0.00173644158289263	56	20	3882	4283	1.54197963165914
R-HSA-622312	Inflammasomes	 17	0.251740288609141	0.764173972326076	10	7	3928	4296	1.23099214292116
R-HSA-622323	Presynaptic nicotinic acetylcholine receptors	  8	1	1	0	8	3938	4295	0
R-HSA-622327	Postsynaptic nicotinic acetylcholine receptors	  8	1	1	0	8	3938	4295	0
R-HSA-629587	Highly sodium permeable acetylcholine nicotinic receptors	  5	1	1	0	5	3938	4298	0
R-HSA-629594	Highly calcium permeable postsynaptic nicotinic acetylcholine receptors	  5	1	1	0	5	3938	4298	0
R-HSA-629597	Highly calcium permeable nicotinic acetylcholine receptors	  5	1	1	0	5	3938	4298	0
R-HSA-629602	Activation of Nicotinic Acetylcholine Receptors	  8	1	1	0	8	3938	4295	0
R-HSA-674695	RNA Polymerase II Pre-transcription Events	 70	0.16520439294031	0.618228588257232	38	32	3900	4271	1.13602989189581
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	 45	8.8192008905121e-06	0.00237166555416218	36	9	3902	4294	1.67414931437278
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	 67	6.05547318753354e-05	0.00976276843901241	48	19	3890	4284	1.49923819197562
R-HSA-6782135	Dual incision in TC-NER	 54	0.000224727544122745	0.0203799791576314	39	15	3899	4288	1.51138479769765
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	 54	0.000630007694958648	0.0304713721795	38	16	3900	4287	1.47263134134643
R-HSA-6782315	tRNA modification in the nucleus and cytosol	 40	0.0819446300132358	0.455885631712684	24	16	3914	4287	1.25561198577958
R-HSA-6782861	Synthesis of wybutosine at G37 of tRNA(Phe)	  5	0.78366872375152	1	2	3	3936	4300	0.837074657186389
R-HSA-6783310	Fanconi Anemia Pathway	 33	0.17016007900559	0.62760402454511	19	14	3919	4289	1.20488018837435
R-HSA-6783589	Interleukin-6 family signaling	 22	0.500897220968094	0.966491845245617	11	11	3927	4292	1.04634332148299
R-HSA-6783783	Interleukin-10 signaling	 36	0.999903627730369	1	7	29	3931	4274	0.406911291687828
R-HSA-6784531	tRNA processing in the nucleus	 53	0.0767187815920939	0.434106091253944	31	22	3907	4281	1.22402426286689
R-HSA-6785631	ERBB2 Regulates Cell Motility	 11	0.440211273532975	0.918433256168249	6	5	3932	4298	1.1414654416178
R-HSA-6785807	Interleukin-4 and 13 signaling	 94	0.999951020525278	1	27	67	3911	4236	0.601090844256184
R-HSA-6787450	tRNA modification in the mitochondrion	  7	0.0491362727338201	0.334726440078746	6	1	3932	4302	1.79373140825655
R-HSA-6787639	GDP-fucose biosynthesis	  6	0.86854805730333	1	2	4	3936	4299	0.697562214321991
R-HSA-6788467	IL-6-type cytokine receptor ligand interactions	 15	0.805145315275593	1	6	9	3932	4294	0.837074657186389
R-HSA-6788656	Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism	 36	0.591779271864294	1	17	19	3921	4284	0.988213136956154
R-HSA-6790901	rRNA modification in the nucleus and cytosol	 53	0.124796965368222	0.552506375388639	30	23	3908	4280	1.18453960922602
R-HSA-6791312	TP53 Regulates Transcription of Cell Cycle Genes	 46	0.973444873362846	1	16	30	3922	4273	0.727891006249034
R-HSA-6793080	rRNA modification in the mitochondrion	  6	0.86854805730333	1	2	4	3936	4299	0.697562214321991
R-HSA-6794361	Neurexins and neuroligins	 53	0.274131830124231	0.772928726676344	28	25	3910	4278	1.10557030194429
R-HSA-6794362	Protein-protein interactions at synapses	 81	0.141967876321655	0.567480409208599	44	37	3894	4266	1.13676805296917
R-HSA-6796648	TP53 Regulates Transcription of DNA Repair Genes	 52	0.00779728126356088	0.147249702974256	34	18	3904	4285	1.36829511270852
R-HSA-6798163	Choline catabolism	  6	0.303133259568907	0.818236200316395	4	2	3934	4301	1.39512442864398
R-HSA-6799198	Complex I biogenesis	 44	0.00494659870873678	0.105268297634917	30	14	3908	4289	1.42683180202225
R-HSA-6802946	Signaling by moderate kinase activity BRAF mutants	 37	0.392824418800691	0.918433256168249	19	18	3919	4285	1.07462287071226
R-HSA-6802948	Signaling by high-kinase activity BRAF mutants	 33	0.398592620002252	0.918433256168249	17	16	3921	4287	1.07805069486126
R-HSA-6802949	Signaling by RAS mutants	 49	0.274651880581819	0.772928726676344	26	23	3912	4280	1.11040515749215
R-HSA-6802952	Signaling by BRAF and RAF fusions	 56	0.230881734176698	0.720590664097588	30	26	3908	4277	1.12108213016034
R-HSA-6802955	Paradoxical activation of RAF signaling by kinase inactive BRAF	 37	0.392824418800691	0.918433256168249	19	18	3919	4285	1.07462287071226
R-HSA-6802957	Oncogenic MAPK signaling	 71	0.196934509554555	0.669358877079889	38	33	3900	4270	1.1200294708832
R-HSA-6803157	Antimicrobial peptides	 40	0.999997570989806	1	6	34	3932	4269	0.313902996444896
R-HSA-6803204	TP53 Regulates Transcription of Genes Involved in Cytochrome C Release	 20	0.915906277694761	1	7	13	3931	4290	0.73244032503809
R-HSA-6803205	TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain	 13	0.983292732593995	1	3	10	3935	4293	0.482927686838301
R-HSA-6803207	TP53 Regulates Transcription of Caspase Activators and Caspases	 11	0.855757090184043	1	4	7	3934	4296	0.760976961078535
R-HSA-6803211	TP53 Regulates Transcription of Death Receptors and Ligands	 12	0.99510376956634	1	2	10	3936	4293	0.348781107160995
R-HSA-6803529	FGFR2 alternative splicing	 24	0.0490245166606896	0.334726440078746	16	8	3922	4295	1.39512442864398
R-HSA-6804114	TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest	 17	0.963149237369588	1	5	12	3933	4291	0.61549607146058
R-HSA-6804115	TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain	 20	0.821370442274037	1	8	12	3930	4291	0.837074657186389
R-HSA-6804116	TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest	 12	0.972463885279028	1	3	9	3935	4294	0.523171660741493
R-HSA-6804756	Regulation of TP53 Activity through Phosphorylation	 80	0.0509620714189202	0.342342433466913	46	34	3892	4269	1.20329481970543
R-HSA-6804757	Regulation of TP53 Degradation	 35	0.100194011152409	0.49578463748403	21	14	3917	4289	1.25561198577958
R-HSA-6804758	Regulation of TP53 Activity through Acetylation	 30	0.213989646620597	0.694628584444041	17	13	3921	4290	1.18585576434738
R-HSA-6804759	Regulation of TP53 Activity through Association with Co-factors	 12	0.972463885279028	1	3	9	3935	4294	0.523171660741493
R-HSA-6804760	Regulation of TP53 Activity through Methylation	 17	0.426382730531353	0.918433256168249	9	8	3929	4295	1.10789292862904
R-HSA-6805567	Keratinization	 80	0.999999999894828	1	12	68	3926	4235	0.313902996444896
R-HSA-6806003	Regulation of TP53 Expression and Degradation	 36	0.135118562225052	0.566564079971367	21	15	3917	4288	1.22073387506348
R-HSA-6806667	Metabolism of fat-soluble vitamins	 41	0.999424204749877	1	10	31	3928	4272	0.510411376333164
R-HSA-6806834	Signaling by MET	 71	0.00571579167546417	0.116811460860542	45	26	3893	4277	1.32635068920379
R-HSA-6807004	Negative regulation of MET activity	 20	0.0378874938186284	0.315946859372585	14	6	3924	4297	1.46488065007618
R-HSA-6807505	RNA polymerase II transcribes snRNA genes	 69	0.0194021474350171	0.218236557583022	42	27	3896	4276	1.27380926093581
R-HSA-6807878	COPI-mediated anterograde transport	 86	0.0205728125849968	0.224444744818273	51	35	3887	4268	1.24101184641005
R-HSA-6809371	Formation of the cornified envelope	 66	0.999999999315788	1	9	57	3929	4246	0.285366360404451
R-HSA-6811434	COPI-dependent Golgi-to-ER retrograde traffic	 76	0.661812276580651	1	35	41	3903	4262	0.963737269786961
R-HSA-6811436	COPI-independent Golgi-to-ER retrograde traffic	 45	0.00336228930805365	0.0841152032066526	31	14	3907	4289	1.44162857626545
R-HSA-6811438	Intra-Golgi traffic	 38	0.00811965231789373	0.147270193915797	26	12	3912	4291	1.43183822939777
R-HSA-6811440	Retrograde transport at the Trans-Golgi-Network	 45	0.00811521751010299	0.147270193915797	30	15	3908	4288	1.39512442864398
R-HSA-6811555	PI5P Regulates TP53 Acetylation	  9	0.700733355278605	1	4	5	3934	4298	0.930082952429321
R-HSA-6811558	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	 79	0.950192096083691	1	31	48	3907	4255	0.821180834581584
R-HSA-6814122	Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding	 34	0.0715568796763298	0.418665453267558	21	13	3917	4290	1.29254175006722
R-HSA-6814848	Glycerophospholipid catabolism	  7	0.73561681688831	1	3	4	3935	4299	0.896865704128274
R-HSA-68616	Assembly of the ORC complex at the origin of replication	  5	0.160967868205754	0.608240564496221	4	1	3934	4302	1.67414931437278
R-HSA-68689	CDC6 association with the ORC:origin complex	  8	0.31592015436873	0.818236200316395	5	3	3933	4300	1.30792915185373
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	 47	0.274802327591016	0.772928726676344	25	22	3913	4281	1.11313119306701
R-HSA-68867	Assembly of the pre-replicative complex	 55	0.47570530136371	0.940392905011912	27	28	3911	4275	1.02731889745602
R-HSA-68874	M/G1 Transition	 70	0.760385607743867	1	31	39	3907	4264	0.926761227599217
R-HSA-68875	Mitotic Prophase	 96	0.686682075602736	1	44	52	3894	4251	0.959148044692737
R-HSA-68884	Mitotic Telophase/Cytokinesis	 11	0.226607480313798	0.719491146466787	7	4	3931	4299	1.33170968188744
R-HSA-68911	G2 Phase	  5	0.961231891425561	1	1	4	3937	4299	0.418537328593195
R-HSA-68949	Orc1 removal from chromatin	 58	0.417420099546758	0.918433256168249	29	29	3909	4274	1.04634332148299
R-HSA-68952	DNA replication initiation	  7	1	1	0	7	3938	4296	0
R-HSA-68962	Activation of the pre-replicative complex	 27	0.822780951951923	1	11	16	3927	4287	0.852576039726878
R-HSA-69002	DNA Replication Pre-Initiation	 70	0.760385607743867	1	31	39	3907	4264	0.926761227599217
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	 41	0.510560623786747	0.970935078787117	20	21	3918	4282	1.02082275266633
R-HSA-69052	Switching of origins to a post-replicative state	 58	0.417420099546758	0.918433256168249	29	29	3909	4274	1.04634332148299
R-HSA-69091	Polymerase switching	 11	0.67363845463036	1	5	6	3933	4297	0.951221201348169
R-HSA-69109	Leading Strand Synthesis	 11	0.67363845463036	1	5	6	3933	4297	0.951221201348169
R-HSA-69166	Removal of the Flap Intermediate	 11	0.855757090184043	1	4	7	3934	4296	0.760976961078535
R-HSA-69183	Processive synthesis on the lagging strand	 12	0.760692490142898	1	5	7	3933	4296	0.871952767902489
R-HSA-69186	Lagging Strand Synthesis	 17	0.251740288609141	0.764173972326076	10	7	3928	4296	1.23099214292116
R-HSA-69190	DNA strand elongation	 28	0.480786590736604	0.944007230255498	14	14	3924	4289	1.04634332148299
R-HSA-69202	Cyclin E associated events during G1/S transition 	 69	0.35533414693411	0.857886601000656	35	34	3903	4269	1.06150771744651
R-HSA-69205	G1/S-Specific Transcription	 21	0.866574233666673	1	8	13	3930	4290	0.797213959225132
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	 41	0.510560623786747	0.970935078787117	20	21	3918	4282	1.02082275266633
R-HSA-69231	Cyclin D associated events in G1	 38	0.0407963087315287	0.32057602598237	24	14	3914	4289	1.3216968271364
R-HSA-69236	G1 Phase	 38	0.0407963087315287	0.32057602598237	24	14	3914	4289	1.3216968271364
R-HSA-69239	Synthesis of DNA	 83	0.513611136302901	0.97535482363707	40	43	3898	4260	1.0085236833571
R-HSA-69273	Cyclin A/B1/B2 associated events during G2/M transition	 21	0.140467860660899	0.566564079971367	13	8	3925	4295	1.29547268374084
R-HSA-69298	Association of licensing factors with the pre-replicative complex	 10	0.323700113595242	0.818236200316395	6	4	3932	4299	1.25561198577958
R-HSA-69300	Removal of licensing factors from origins	 59	0.467329978154731	0.931450272393565	29	30	3909	4273	1.02860868891548
R-HSA-69304	Regulation of DNA replication	 61	0.565508735103503	1	29	32	3909	4271	0.994883813869069
R-HSA-69306	DNA Replication	 89	0.586244095540717	1	42	47	3896	4256	0.987559988815403
R-HSA-69416	Dimerization of procaspase-8	 11	0.991330455518455	1	2	9	3936	4294	0.380488480539268
R-HSA-69473	G2/M DNA damage checkpoint	 63	0.132915895798302	0.566564079971367	35	28	3903	4275	1.16260369053665
R-HSA-69478	G2/M DNA replication checkpoint	  5	1	1	0	5	3938	4298	0
R-HSA-69541	Stabilization of p53	 48	0.324908520532041	0.818236200316395	25	23	3913	4280	1.08994095987811
R-HSA-69563	p53-Dependent G1 DNA Damage Response	 56	0.420628249471698	0.918433256168249	28	28	3910	4275	1.04634332148299
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	 56	0.420628249471698	0.918433256168249	28	28	3910	4275	1.04634332148299
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	 42	0.446233156665143	0.918433256168249	21	21	3917	4282	1.04634332148299
R-HSA-69610	p53-Independent DNA Damage Response	 42	0.446233156665143	0.918433256168249	21	21	3917	4282	1.04634332148299
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	 42	0.446233156665143	0.918433256168249	21	21	3917	4282	1.04634332148299
R-HSA-69615	G1/S DNA Damage Checkpoints	 56	0.420628249471698	0.918433256168249	28	28	3910	4275	1.04634332148299
R-HSA-69618	Mitotic Spindle Checkpoint	 86	0.229889472597445	0.72045275321575	45	41	3893	4262	1.09501045271475
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	 68	0.312103914913105	0.818236200316395	35	33	3903	4270	1.07711812505602
R-HSA-70171	Glycolysis	 67	0.00980304978302046	0.16108520665347	42	25	3896	4278	1.31183341797867
R-HSA-70221	Glycogen breakdown (glycogenolysis)	 16	0.527427538082664	0.988756276173056	8	8	3930	4295	1.04634332148299
R-HSA-70263	Gluconeogenesis	 28	0.335158047376924	0.818236200316395	15	13	3923	4290	1.12108213016034
R-HSA-70268	Pyruvate metabolism	 23	0.029071050208216	0.266975277545073	16	7	3922	4296	1.45578201249807
R-HSA-70326	Glucose metabolism	 84	0.0198723296165656	0.221805771335667	50	34	3888	4269	1.24564681128927
R-HSA-70350	Fructose catabolism	  5	0.961231891425561	1	1	4	3937	4299	0.418537328593195
R-HSA-70370	Galactose catabolism	  6	0.303133259568907	0.818236200316395	4	2	3934	4301	1.39512442864398
R-HSA-70614	Amino acid synthesis and interconversion (transamination)	 26	0.207170658079939	0.686311928936054	15	11	3923	4292	1.20731921709575
R-HSA-70635	Urea cycle	  6	0.979768658250007	1	1	5	3937	4298	0.348781107160995
R-HSA-70895	Branched-chain amino acid catabolism	 19	0.00118861039288662	0.0431722167520777	16	3	3922	4300	1.76226243618187
R-HSA-71032	Propionyl-CoA catabolism	  5	0.024883004971568	0.252484197298917	5	0	3933	4303	2.09268664296597
R-HSA-71064	Lysine catabolism	 11	0.087058396650189	0.464288021493932	8	3	3930	4300	1.52195392215707
R-HSA-71182	Phenylalanine and tyrosine catabolism	  9	0.886499944435254	1	3	6	3935	4297	0.697562214321991
R-HSA-71240	Tryptophan catabolism	 11	0.440211273532975	0.918433256168249	6	5	3932	4298	1.1414654416178
R-HSA-71288	Creatine metabolism	  9	0.700733355278605	1	4	5	3934	4298	0.930082952429321
R-HSA-71336	Pentose phosphate pathway (hexose monophosphate shunt)	 13	0.237285205121634	0.72945091659214	8	5	3930	4298	1.28780716490214
R-HSA-71384	Ethanol oxidation	 10	0.789532131800886	1	4	6	3934	4297	0.837074657186389
R-HSA-71403	Citric acid cycle (TCA cycle)	 16	0.00118469047732047	0.0431722167520777	14	2	3924	4301	1.83110081259523
R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	 41	0.000257496865951098	0.0219781148526496	31	10	3907	4293	1.58227526663281
R-HSA-72086	mRNA Capping	 24	0.0190943169819793	0.218236557583022	17	7	3921	4296	1.48231970543423
R-HSA-72165	mRNA Splicing - Minor Pathway	 47	0.274802327591016	0.772928726676344	25	22	3913	4281	1.11313119306701
R-HSA-72187	mRNA 3'-end processing	 49	0.00439914814091444	0.101320062737569	33	16	3905	4287	1.40936039220157
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	 71	0.0203030625293175	0.223179876742724	43	28	3895	4275	1.26740176968362
R-HSA-72306	tRNA processing	 98	0.00873679442613861	0.151758309255453	59	39	3879	4264	1.25988277484686
R-HSA-72613	Eukaryotic Translation Initiation	 67	0.549682664453634	1	32	35	3906	4268	0.999492127983748
R-HSA-72649	Translation initiation complex formation	 33	0.2725824910408	0.772928726676344	18	15	3920	4288	1.1414654416178
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	 34	0.332778119166757	0.818236200316395	18	16	3920	4287	1.10789292862904
R-HSA-72689	Formation of a pool of free 40S subunits	 53	0.480113870486876	0.944007230255498	26	27	3912	4276	1.02660099466255
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	 30	0.213989646620597	0.694628584444041	17	13	3921	4290	1.18585576434738
R-HSA-72702	Ribosomal scanning and start codon recognition	 33	0.2725824910408	0.772928726676344	18	15	3920	4288	1.1414654416178
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	 60	0.618564085422606	1	28	32	3910	4271	0.976587100050787
R-HSA-72731	Recycling of eIF2:GDP	  8	0.587348598285987	1	4	4	3934	4299	1.04634332148299
R-HSA-72737	Cap-dependent Translation Initiation	 67	0.549682664453634	1	32	35	3906	4268	0.999492127983748
R-HSA-72764	Eukaryotic Translation Termination	 47	0.609660942750936	1	22	25	3916	4278	0.979555449898966
R-HSA-727802	Transport of nucleotide sugars	  7	0.0491362727338201	0.334726440078746	6	1	3932	4302	1.79373140825655
R-HSA-73614	Pyrimidine salvage	  9	0.886499944435254	1	3	6	3935	4297	0.697562214321991
R-HSA-73621	Pyrimidine catabolism	  8	0.954101488609214	1	2	6	3936	4297	0.523171660741493
R-HSA-73728	RNA Polymerase I Promoter Opening	 22	0.999987198953528	1	2	20	3936	4283	0.190244240269634
R-HSA-73762	RNA Polymerase I Transcription Initiation	 43	0.0163937204837687	0.203310157452551	28	15	3910	4288	1.36267967448947
R-HSA-73772	RNA Polymerase I Promoter Escape	 26	0.00791555949827153	0.147249702974256	19	7	3919	4296	1.52927100832129
R-HSA-73776	RNA Polymerase II Promoter Escape	 40	0.141348171571078	0.566564079971367	23	17	3915	4286	1.20329481970543
R-HSA-73777	RNA Polymerase I Chain Elongation	 45	0.61705619945913	1	21	24	3917	4279	0.976587100050787
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	 40	0.141348171571078	0.566564079971367	23	17	3915	4286	1.20329481970543
R-HSA-73780	RNA Polymerase III Chain Elongation	 16	0.0256611463631857	0.255081422358691	12	4	3926	4299	1.56951498222448
R-HSA-73817	Purine ribonucleoside monophosphate biosynthesis	 11	0.955170261510425	1	3	8	3935	4295	0.570732720808902
R-HSA-73854	RNA Polymerase I Promoter Clearance	 64	0.606405507712536	1	30	34	3908	4269	0.9809468638903
R-HSA-73856	RNA Polymerase II Transcription Termination	 57	0.0137871857652609	0.190312953799443	36	21	3902	4282	1.3216968271364
R-HSA-73863	RNA Polymerase I Transcription Termination	 27	0.00500586666906221	0.105268297634917	20	7	3918	4296	1.55013825404887
R-HSA-73864	RNA Polymerase I Transcription	 66	0.503064213043253	0.969384028055457	32	34	3906	4269	1.01463594810471
R-HSA-73884	Base Excision Repair	 35	0.0104288140672497	0.16108520665347	24	11	3914	4292	1.43498512660524
R-HSA-73886	Chromosome Maintenance	 69	0.994788899048414	1	23	46	3915	4257	0.697562214321991
R-HSA-73887	Death Receptor Signalling	 45	0.499531803565555	0.96514067506474	22	23	3916	4280	1.02309124767225
R-HSA-73893	DNA Damage Bypass	 43	0.274832196519748	0.772928726676344	23	20	3915	4283	1.11934401833064
R-HSA-73928	Depyrimidination	  7	0.0491362727338201	0.334726440078746	6	1	3932	4302	1.79373140825655
R-HSA-73929	Base-Excision Repair, AP Site Formation	  9	0.0140341047943077	0.190312953799443	8	1	3930	4302	1.86016590485864
R-HSA-73933	Resolution of Abasic Sites (AP sites)	 35	0.0104288140672497	0.16108520665347	24	11	3914	4292	1.43498512660524
R-HSA-73942	DNA Damage Reversal	  8	0.954101488609214	1	2	6	3936	4297	0.523171660741493
R-HSA-73943	Reversal of alkylation damage by DNA dioxygenases	  7	0.921720553469337	1	2	5	3936	4298	0.597910469418849
R-HSA-73980	RNA Polymerase III Transcription Termination	 21	0.00191966005977888	0.0625431344392312	17	4	3921	4299	1.69407966335341
R-HSA-74158	RNA Polymerase III Transcription	 38	0.00104060032297898	0.0431722167520777	28	10	3910	4293	1.54197963165914
R-HSA-74182	Ketone body metabolism	  8	0.117259782578872	0.535576201184411	6	2	3932	4301	1.56951498222448
R-HSA-74217	Purine salvage	 13	0.237285205121634	0.72945091659214	8	5	3930	4298	1.28780716490214
R-HSA-74259	Purine catabolism	 16	0.527427538082664	0.988756276173056	8	8	3930	4295	1.04634332148299
R-HSA-74713	IRS activation	  5	0.160967868205754	0.608240564496221	4	1	3934	4302	1.67414931437278
R-HSA-74749	Signal attenuation	 10	0.137803517982411	0.566564079971367	7	3	3931	4300	1.46488065007618
R-HSA-74751	Insulin receptor signalling cascade	 42	0.446233156665143	0.918433256168249	21	21	3917	4282	1.04634332148299
R-HSA-74752	Signaling by Insulin receptor	 62	0.0221240563750535	0.234321210220457	38	24	3900	4279	1.28261439407592
R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation	 38	0.00104060032297898	0.0431722167520777	28	10	3910	4293	1.54197963165914
R-HSA-75035	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	 11	0.67363845463036	1	5	6	3933	4297	0.951221201348169
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	 26	0.113176290538803	0.530161290572901	16	10	3922	4293	1.28780716490214
R-HSA-75072	mRNA Editing	  5	0.78366872375152	1	2	3	3936	4300	0.837074657186389
R-HSA-75105	Fatty acyl-CoA biosynthesis	 30	0.0115344556366654	0.174338490925015	21	9	3917	4294	1.46488065007618
R-HSA-75109	Triglyceride biosynthesis	  7	0.451634376327358	0.918433256168249	4	3	3934	4300	1.1958209388377
R-HSA-75153	Apoptotic execution  phase	 45	0.61705619945913	1	21	24	3917	4279	0.976587100050787
R-HSA-75157	FasL/ CD95L signaling	  5	1	1	0	5	3938	4298	0
R-HSA-75158	TRAIL  signaling	  7	0.921720553469337	1	2	5	3936	4298	0.597910469418849
R-HSA-75205	Dissolution of Fibrin Clot	 11	0.991330455518455	1	2	9	3936	4294	0.380488480539268
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	 41	0.510560623786747	0.970935078787117	20	21	3918	4282	1.02082275266633
R-HSA-75876	Synthesis of very long-chain fatty acyl-CoAs	 19	0.057303335058834	0.374536662929586	13	6	3925	4297	1.43183822939777
R-HSA-75892	Platelet Adhesion to exposed collagen	  9	0.886499944435254	1	3	6	3935	4297	0.697562214321991
R-HSA-75893	TNF signaling	 38	0.330753101161632	0.818236200316395	20	18	3918	4285	1.10141402261367
R-HSA-75953	RNA Polymerase II Transcription Initiation	 40	0.141348171571078	0.566564079971367	23	17	3915	4286	1.20329481970543
R-HSA-75955	RNA Polymerase II Transcription Elongation	 49	0.07227946488213	0.419510014175883	29	20	3909	4283	1.23852882951047
R-HSA-76009	Platelet Aggregation (Plug Formation)	 32	0.981259287972804	1	10	22	3928	4281	0.653964575926866
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	 40	0.141348171571078	0.566564079971367	23	17	3915	4286	1.20329481970543
R-HSA-76046	RNA Polymerase III Transcription Initiation	 33	0.00898924453418539	0.152486778775323	23	10	3915	4293	1.45853917540053
R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	 25	0.0123715976188282	0.181325132776967	18	7	3920	4296	1.5067343829355
R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	 24	0.0190943169819793	0.218236557583022	17	7	3921	4296	1.48231970543423
R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	 26	0.00791555949827153	0.147249702974256	19	7	3919	4296	1.52927100832129
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	 22	0.015794587791697	0.197568507635796	16	6	3922	4297	1.52195392215707
R-HSA-77111	Synthesis of Ketone Bodies	  7	0.191757422000069	0.666494570255742	5	2	3933	4301	1.49477617354712
R-HSA-77286	mitochondrial fatty acid beta-oxidation of saturated fatty acids	 10	0.567535190495185	1	5	5	3933	4298	1.04634332148299
R-HSA-77288	mitochondrial fatty acid beta-oxidation of unsaturated fatty acids	  6	0.86854805730333	1	2	4	3936	4299	0.697562214321991
R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	 29	0.0415356946138425	0.32057602598237	19	10	3919	4293	1.3710705591846
R-HSA-77310	Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA	  5	0.458521658108405	0.918433256168249	3	2	3935	4301	1.25561198577958
R-HSA-77346	Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA	  6	0.0898851725241767	0.472548497581813	5	1	3933	4302	1.74390553580498
R-HSA-77348	Beta oxidation of octanoyl-CoA to hexanoyl-CoA	  5	0.160967868205754	0.608240564496221	4	1	3934	4302	1.67414931437278
R-HSA-77350	Beta oxidation of hexanoyl-CoA to butanoyl-CoA	  5	0.458521658108405	0.918433256168249	3	2	3935	4301	1.25561198577958
R-HSA-77387	Insulin receptor recycling	 22	0.00110644598765246	0.0431722167520777	18	4	3920	4299	1.7121981624267
R-HSA-774815	Nucleosome assembly	 36	0.999599923160969	1	8	28	3930	4275	0.465041476214661
R-HSA-77588	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	 10	0.789532131800886	1	4	6	3934	4297	0.837074657186389
R-HSA-77595	Processing of Intronless Pre-mRNAs	 18	0.0318843572309661	0.284161595567599	13	5	3925	4298	1.51138479769765
R-HSA-804914	Transport of fatty acids	  6	0.86854805730333	1	2	4	3936	4299	0.697562214321991
R-HSA-83936	Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane	  6	0.86854805730333	1	2	4	3936	4299	0.697562214321991
R-HSA-844456	The NLRP3 inflammasome	 12	0.551762804912806	1	6	6	3932	4297	1.04634332148299
R-HSA-877300	Interferon gamma signaling	 71	0.994017309660832	1	24	47	3914	4256	0.707387034242019
R-HSA-877312	Regulation of IFNG signaling	 13	0.435263368689903	0.918433256168249	7	6	3931	4297	1.12683126928937
R-HSA-879415	Advanced glycosylation endproduct receptor signaling	 11	0.440211273532975	0.918433256168249	6	5	3932	4298	1.1414654416178
R-HSA-879518	Transport of organic anions	  9	0.886499944435254	1	3	6	3935	4297	0.697562214321991
R-HSA-8847993	ERBB2 Activates PTK6 Signaling	 10	0.137803517982411	0.566564079971367	7	3	3931	4300	1.46488065007618
R-HSA-8848021	Signaling by PTK6	 47	0.186569547081308	0.666494570255742	26	21	3912	4282	1.15765644078969
R-HSA-8849469	PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1	  8	0.587348598285987	1	4	4	3934	4299	1.04634332148299
R-HSA-8849471	PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases	 14	0.0193352479713472	0.218236557583022	11	3	3927	4300	1.64425379090184
R-HSA-8849473	PTK6 Expression	  5	0.78366872375152	1	2	3	3936	4300	0.837074657186389
R-HSA-8849932	Synaptic adhesion-like molecules	 18	0.184992219123502	0.666063796397523	11	7	3927	4296	1.27886405959032
R-HSA-8850843	Phosphate bond hydrolysis by NTPDase proteins	  7	0.73561681688831	1	3	4	3935	4299	0.896865704128274
R-HSA-8851680	Butyrophilin (BTN) family interactions	  9	0.445617652045213	0.918433256168249	5	4	3933	4299	1.16260369053665
R-HSA-8851708	Signaling by FGFR2 IIIa TM	 17	0.251740288609141	0.764173972326076	10	7	3928	4296	1.23099214292116
R-HSA-8851805	MET activates RAS signaling	 10	0.323700113595242	0.818236200316395	6	4	3932	4299	1.25561198577958
R-HSA-8851907	MET activates PI3K/AKT signaling	  6	0.613910056647902	1	3	3	3935	4300	1.04634332148299
R-HSA-8852135	Protein ubiquitination	 66	0.313396803841339	0.818236200316395	34	32	3904	4271	1.07805069486126
R-HSA-8852276	The role of GTSE1 in G2/M progression after G2 checkpoint	 63	0.74472115375657	1	28	35	3910	4268	0.930082952429321
R-HSA-8853334	Signaling by FGFR3 fusions in cancer	 10	0.0406679147997326	0.32057602598237	8	2	3930	4301	1.67414931437278
R-HSA-8853338	Signaling by FGFR3 point mutants in cancer	 20	0.680637955746851	1	9	11	3929	4292	0.941708989334688
R-HSA-8853659	RET signaling	 38	0.704456031122546	1	17	21	3921	4282	0.936201919221619
R-HSA-8854050	FBXL7 down-regulates AURKA during mitotic entry and in early mitosis	 46	0.326135313022753	0.818236200316395	24	22	3914	4281	1.09183650937355
R-HSA-8854214	TBC/RABGAPs	 39	0.0133905585434929	0.190312953799443	26	13	3912	4290	1.39512442864398
R-HSA-8854518	AURKA Activation by TPX2	 69	0.010435568177413	0.16108520665347	43	26	3895	4277	1.30413805286285
R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis	 95	8.38097721054613e-05	0.0121607979325024	64	31	3874	4272	1.4098099489455
R-HSA-8857538	PTK6 promotes HIF1A stabilization	  6	0.303133259568907	0.818236200316395	4	2	3934	4301	1.39512442864398
R-HSA-8862803	Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models	 20	0.0933613259335015	0.478682982083076	13	7	3925	4296	1.36024631792788
R-HSA-8863678	Neurodegenerative Diseases	 20	0.0933613259335015	0.478682982083076	13	7	3925	4296	1.36024631792788
R-HSA-8863795	Downregulation of ERBB2 signaling	 25	0.0333800956286754	0.286594785545609	17	8	3921	4295	1.42302691721686
R-HSA-8864260	Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	 32	0.95660663294489	1	11	21	3927	4282	0.719361033519553
R-HSA-8865999	MET activates PTPN11	  5	0.458521658108405	0.918433256168249	3	2	3935	4301	1.25561198577958
R-HSA-8866376	Reelin signalling pathway	  7	0.451634376327358	0.918433256168249	4	3	3934	4300	1.1958209388377
R-HSA-8866427	VLDLR internalisation and degradation	 12	0.0537310911895786	0.355999147562002	9	3	3929	4300	1.56951498222448
R-HSA-8866652	Synthesis of active ubiquitin: roles of E1 and E2 enzymes	 26	0.0541246520793542	0.356976682577923	17	9	3921	4294	1.36829511270852
R-HSA-8866654	E3 ubiquitin ligases ubiquitinate target proteins	 49	0.707853727278477	1	22	27	3916	4276	0.939573594801049
R-HSA-8866904	Negative regulation of activity of TFAP2 (AP-2) family transcription factors	  8	0.994492178633106	1	1	7	3937	4296	0.261585830370747
R-HSA-8866907	Activation of the TFAP2 (AP-2) family of transcription factors	 10	0.789532131800886	1	4	6	3934	4297	0.837074657186389
R-HSA-8866910	TFAP2 (AP-2) family regulates transcription of growth factors and their receptors	 10	0.323700113595242	0.818236200316395	6	4	3932	4299	1.25561198577958
R-HSA-8868766	rRNA processing in the mitochondrion	  8	0.824577748049705	1	3	5	3935	4298	0.78475749111224
R-HSA-8873719	RAB geranylgeranylation	 54	0.0038733886158743	0.0921358505185837	36	18	3902	4285	1.39512442864398
R-HSA-8874081	MET activates PTK2 signaling	 27	0.560353574490703	1	13	14	3925	4289	1.00758986513176
R-HSA-8874211	CREB3 factors activate genes	  7	0.451634376327358	0.918433256168249	4	3	3934	4300	1.1958209388377
R-HSA-8875360	InlB-mediated entry of Listeria monocytogenes into host cell	 14	0.0193352479713472	0.218236557583022	11	3	3927	4300	1.64425379090184
R-HSA-8875555	MET activates RAP1 and RAC1	 10	0.323700113595242	0.818236200316395	6	4	3932	4299	1.25561198577958
R-HSA-8875656	MET receptor recycling	 10	0.0406679147997326	0.32057602598237	8	2	3930	4301	1.67414931437278
R-HSA-8875878	MET promotes cell motility	 37	0.273983557677975	0.772928726676344	20	17	3918	4286	1.1311819691708
R-HSA-8876198	RAB GEFs exchange GTP for GDP on RABs	 82	0.0191615815943393	0.218236557583022	49	33	3889	4270	1.25050787201625
R-HSA-8876384	Listeria monocytogenes entry into host cells	 18	0.0851243609697732	0.464288021493932	12	6	3926	4297	1.39512442864398
R-HSA-8876493	InlA-mediated entry of Listeria monocytogenes into host cells	  7	0.73561681688831	1	3	4	3935	4299	0.896865704128274
R-HSA-8876725	Protein methylation	 15	0.430676252621717	0.918433256168249	8	7	3930	4296	1.11609954291519
R-HSA-8877330	RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)	  7	0.989443342380119	1	1	6	3937	4297	0.298955234709425
R-HSA-8878159	Transcriptional regulation by RUNX3	100	0.124894618282201	0.552506375388639	54	46	3884	4257	1.13005078720163
R-HSA-888590	GABA synthesis, release, reuptake and degradation	 18	0.000338918768402348	0.0220513146360007	16	2	3922	4301	1.86016590485864
R-HSA-8931987	RUNX1 regulates estrogen receptor mediated transcription	  6	0.613910056647902	1	3	3	3935	4300	1.04634332148299
R-HSA-8934593	Regulation of RUNX1 Expression and Activity	 17	0.12396186136289	0.551744358397404	11	6	3927	4297	1.35409135721328
R-HSA-8934903	Receptor Mediated Mitophagy	 10	0.137803517982411	0.566564079971367	7	3	3931	4300	1.46488065007618
R-HSA-8935690	Digestion	 11	1	1	0	11	3938	4292	0
R-HSA-8935964	RUNX1 regulates expression of components of tight junctions	  5	1	1	0	5	3938	4298	0
R-HSA-8936459	RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function	 54	0.880578904132087	1	22	32	3916	4271	0.852576039726878
R-HSA-8937144	Aryl hydrocarbon receptor signalling	  7	0.921720553469337	1	2	5	3936	4298	0.597910469418849
R-HSA-8939236	RUNX1 regulates transcription of genes involved in differentiation of HSCs	 77	0.972008587715579	1	29	48	3909	4255	0.788154709688483
R-HSA-8939242	RUNX1 regulates transcription of genes involved in differentiation of keratinocytes	  7	0.989443342380119	1	1	6	3937	4297	0.298955234709425
R-HSA-8939243	RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known	 33	0.398592620002252	0.918433256168249	17	16	3921	4287	1.07805069486126
R-HSA-8939245	RUNX1 regulates transcription of genes involved in BCR signaling	  5	0.961231891425561	1	1	4	3937	4299	0.418537328593195
R-HSA-8939246	RUNX1 regulates transcription of genes involved in differentiation of myeloid cells	  5	0.78366872375152	1	2	3	3936	4300	0.837074657186389
R-HSA-8939256	RUNX1 regulates transcription of genes involved in WNT signaling	  6	0.979768658250007	1	1	5	3937	4298	0.348781107160995
R-HSA-8939902	Regulation of RUNX2 expression and activity	 62	0.411264906359635	0.918433256168249	31	31	3907	4272	1.04634332148299
R-HSA-8940973	RUNX2 regulates osteoblast differentiation	 20	0.821370442274037	1	8	12	3930	4291	0.837074657186389
R-HSA-8941326	RUNX2 regulates bone development	 27	0.407972319056764	0.918433256168249	14	13	3924	4290	1.08509677783421
R-HSA-8941332	RUNX2 regulates genes involved in cell migration	  7	0.921720553469337	1	2	5	3936	4298	0.597910469418849
R-HSA-8941855	RUNX3 regulates CDKN1A transcription	  7	0.73561681688831	1	3	4	3935	4299	0.896865704128274
R-HSA-8941856	RUNX3 regulates NOTCH signaling	 13	0.435263368689903	0.918433256168249	7	6	3931	4297	1.12683126928937
R-HSA-8941858	Regulation of RUNX3 expression and activity	 48	0.759449963816505	1	21	27	3917	4276	0.915550406297613
R-HSA-8943723	Regulation of PTEN mRNA translation	  9	0.0012929655587976	0.0457583664833004	9	0	3929	4303	2.09268664296597
R-HSA-8943724	Regulation of PTEN gene transcription	 55	0.273778762709046	0.772928726676344	29	26	3909	4277	1.10341659356388
R-HSA-8948216	Collagen chain trimerization	 36	0.591779271864294	1	17	19	3921	4284	0.988213136956154
R-HSA-8948700	Competing endogenous RNAs (ceRNAs) regulate PTEN translation	  8	0.00270864769607649	0.0727823667964258	8	0	3930	4303	2.09268664296597
R-HSA-8948747	Regulation of PTEN localization	  8	0.117259782578872	0.535576201184411	6	2	3932	4301	1.56951498222448
R-HSA-8948751	Regulation of PTEN stability and activity	 59	0.272919995885891	0.772928726676344	31	28	3907	4275	1.09954721918551
R-HSA-8949215	Mitochondrial calcium ion transport	 20	0.0933613259335015	0.478682982083076	13	7	3925	4296	1.36024631792788
R-HSA-8949275	RUNX3 Regulates Immune Response and Cell Migration	  5	1	1	0	5	3938	4298	0
R-HSA-8949613	Cristae formation	 25	0.000201780776778693	0.0195189271403922	21	4	3917	4299	1.75785678009142
R-HSA-8949664	Processing of SMDT1	 14	0.166345837020011	0.618228588257232	9	5	3929	4298	1.34529855619241
R-HSA-8950505	Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation	 27	0.268555902371867	0.772928726676344	15	12	3923	4291	1.16260369053665
R-HSA-8951430	RUNX3 regulates WNT signaling	  9	0.700733355278605	1	4	5	3934	4298	0.930082952429321
R-HSA-8951671	RUNX3 regulates YAP1-mediated transcription	 22	0.0436098425970425	0.329572300043275	15	7	3923	4296	1.42683180202225
R-HSA-8951936	RUNX3 regulates p14-ARF	 10	0.928057578421412	1	3	7	3935	4296	0.627805992889792
R-HSA-8952158	RUNX3 regulates BCL2L11 (BIM) transcription	  5	0.160967868205754	0.608240564496221	4	1	3934	4302	1.67414931437278
R-HSA-8953750	Transcriptional Regulation by E2F6	 23	0.029071050208216	0.266975277545073	16	7	3922	4296	1.45578201249807
R-HSA-8955332	Carboxyterminal post-translational modifications of tubulin	 32	0.216715720839776	0.698787802085589	18	14	3920	4289	1.17713623666836
R-HSA-8956319	Nucleobase catabolism	 29	0.692316768513358	1	13	16	3925	4287	0.938100908915781
R-HSA-8956320	Nucleobase biosynthesis	 14	0.958809377392206	1	4	10	3934	4293	0.597910469418849
R-HSA-8956321	Nucleotide salvage	 21	0.418494363546959	0.918433256168249	11	10	3927	4293	1.09616919393456
R-HSA-8957275	Post-translational protein phosphorylation	 94	0.975302223480801	1	36	58	3902	4245	0.801454459008245
R-HSA-8963743	Digestion and absorption	 13	1	1	0	13	3938	4290	0
R-HSA-8963888	Chylomicron assembly	  6	0.979768658250007	1	1	5	3937	4298	0.348781107160995
R-HSA-8963889	Assembly of active LPL and LIPC lipase complexes	 14	0.989970011285392	1	3	11	3935	4292	0.448432852064137
R-HSA-8963896	HDL assembly	  8	0.587348598285987	1	4	4	3934	4299	1.04634332148299
R-HSA-8963898	Plasma lipoprotein assembly	 14	0.880263602988144	1	5	9	3933	4294	0.747388086773562
R-HSA-8963899	Plasma lipoprotein remodeling	 22	0.996002739969978	1	5	17	3933	4286	0.475610600674085
R-HSA-8963901	Chylomicron remodeling	  6	1	1	0	6	3938	4297	0
R-HSA-8964038	LDL clearance	 19	0.132817548245669	0.566564079971367	12	7	3926	4296	1.3216968271364
R-HSA-8964043	Plasma lipoprotein clearance	 29	0.404736326220633	0.918433256168249	15	14	3923	4289	1.08242412567205
R-HSA-8964058	HDL remodeling	  7	0.921720553469337	1	2	5	3936	4298	0.597910469418849
R-HSA-8978934	Metabolism of cofactors	  8	0.587348598285987	1	4	4	3934	4299	1.04634332148299
R-HSA-8979227	Triglyceride metabolism	 28	0.969282751164417	1	9	19	3929	4284	0.672649278096205
R-HSA-8982491	Glycogen metabolism	 24	0.493658163779772	0.959013532174145	12	12	3926	4291	1.04634332148299
R-HSA-8983432	Interleukin-15 signaling	 12	0.328659742153142	0.818236200316395	7	5	3931	4298	1.22073387506348
R-HSA-8984722	Interleukin-35 Signalling	 11	0.087058396650189	0.464288021493932	8	3	3930	4300	1.52195392215707
R-HSA-9006921	Integrin signaling	 24	0.888416350583373	1	9	15	3929	4288	0.78475749111224
R-HSA-9006927	Signaling by Non-Receptor Tyrosine Kinases	 47	0.186569547081308	0.666494570255742	26	21	3912	4282	1.15765644078969
R-HSA-9006931	Signaling by Nuclear Receptors	 35	0.659992934165155	1	16	19	3922	4284	0.956656751070159
R-HSA-9006936	Signaling by TGF-beta family members	 96	0.294451604533072	0.818236200316395	49	47	3889	4256	1.06814214068055
R-HSA-901032	ER Quality Control Compartment (ERQC)	 16	0.00655280208046594	0.129176665977451	13	3	3925	4300	1.70030789740985
R-HSA-901042	Calnexin/calreticulin cycle	 21	0.000364735734847703	0.0220513146360007	18	3	3920	4300	1.79373140825655
R-HSA-9010642	ROBO receptors bind AKAP5	  9	0.212162156227543	0.693349749293164	6	3	3932	4300	1.39512442864398
R-HSA-9012546	Interleukin-18 signaling	  6	1	1	0	6	3938	4297	0
R-HSA-9013957	TLR3-mediated TICAM1-dependent programmed cell death	  6	1	1	0	6	3938	4297	0
R-HSA-9013973	TICAM1-dependent activation of IRF3/IRF7	 10	0.567535190495185	1	5	5	3933	4298	1.04634332148299
R-HSA-9014325	TICAM1,TRAF6-dependent induction of TAK1 complex	 14	0.538655708122675	0.996925296538267	7	7	3931	4296	1.04634332148299
R-HSA-909733	Interferon alpha/beta signaling	 52	0.999380450697713	1	14	38	3924	4265	0.563415634644685
R-HSA-912446	Meiotic recombination	 34	0.977230432833684	1	11	23	3927	4280	0.677045678606638
R-HSA-912526	Interleukin receptor SHC signaling	 22	0.901961873278792	1	8	14	3930	4289	0.760976961078535
R-HSA-912631	Regulation of signaling by CBL	 20	0.508821033705273	0.970935078787117	10	10	3928	4293	1.04634332148299
R-HSA-912694	Regulation of IFNA signaling	 14	0.538655708122675	0.996925296538267	7	7	3931	4296	1.04634332148299
R-HSA-913709	O-linked glycosylation of mucins	 54	0.997902269795989	1	16	38	3922	4265	0.620055301619547
R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	 27	0.407972319056764	0.918433256168249	14	13	3924	4290	1.08509677783421
R-HSA-917937	Iron uptake and transport	 50	0.000431554226732013	0.0250474073195261	36	14	3902	4289	1.5067343829355
R-HSA-917977	Transferrin endocytosis and recycling	 27	0.000333389673857901	0.0220513146360007	22	5	3916	4298	1.70515207945376
R-HSA-918233	TRAF3-dependent IRF activation pathway	 13	0.936367727562474	1	4	9	3934	4294	0.643903582451068
R-HSA-927802	Nonsense-Mediated Decay (NMD)	 69	0.35533414693411	0.857886601000656	35	34	3903	4269	1.06150771744651
R-HSA-933541	TRAF6 mediated IRF7 activation	 21	0.978240050417229	1	6	15	3932	4288	0.597910469418849
R-HSA-933542	TRAF6 mediated NF-kB activation	 23	0.929046327174402	1	8	15	3930	4288	0.727891006249034
R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	 11	0.955170261510425	1	3	8	3935	4295	0.570732720808902
R-HSA-936440	Negative regulators of DDX58/IFIH1 signaling	 31	0.271541935044563	0.772928726676344	17	14	3921	4289	1.14760235259424
R-HSA-936837	Ion transport by P-type ATPases	 48	0.228704630085272	0.719761606298485	26	22	3912	4281	1.13353859827324
R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	 14	0.33187102925713	0.818236200316395	8	6	3930	4297	1.1958209388377
R-HSA-937039	IRAK1 recruits IKK complex	 11	0.226607480313798	0.719491146466787	7	4	3931	4299	1.33170968188744
R-HSA-937041	IKK complex recruitment mediated by RIP1	 19	0.422334246450265	0.918433256168249	10	9	3928	4294	1.10141402261367
R-HSA-937042	IRAK2 mediated activation of TAK1 complex	  9	0.212162156227543	0.693349749293164	6	3	3932	4300	1.39512442864398
R-HSA-937061	TRIF(TICAM1)-mediated TLR4 signaling 	 93	0.145431670000797	0.573853740440181	50	43	3888	4260	1.12510034568063
R-HSA-937072	TRAF6-mediated induction of TAK1 complex within TLR4 complex	 15	0.430676252621717	0.918433256168249	8	7	3930	4296	1.11609954291519
R-HSA-964739	N-glycan trimming and elongation in the cis-Golgi	  5	0.458521658108405	0.918433256168249	3	2	3935	4301	1.25561198577958
R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	 12	0.760692490142898	1	5	7	3933	4296	0.871952767902489
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	 85	0.198324623149086	0.669358877079889	45	40	3893	4263	1.10789292862904
R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	 11	0.226607480313798	0.719491146466787	7	4	3931	4299	1.33170968188744
R-HSA-975155	MyD88 dependent cascade initiated on endosome	 87	0.198362727184254	0.669358877079889	46	41	3892	4262	1.10647799513143
R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	 14	0.538655708122675	0.996925296538267	7	7	3931	4296	1.04634332148299
R-HSA-975576	N-glycan antennae elongation in the medial/trans-Golgi	 24	0.493658163779772	0.959013532174145	12	12	3926	4291	1.04634332148299
R-HSA-975577	N-Glycan antennae elongation	 14	0.538655708122675	0.996925296538267	7	7	3931	4296	1.04634332148299
R-HSA-975578	Reactions specific to the complex N-glycan synthesis pathway	  9	0.445617652045213	0.918433256168249	5	4	3933	4299	1.16260369053665
R-HSA-975634	Retinoid metabolism and transport	 39	0.99868565861581	1	10	29	3928	4274	0.536586318709224
R-HSA-975871	MyD88 cascade initiated on plasma membrane	 80	0.117906338261745	0.535576201184411	44	36	3894	4267	1.15097765363129
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	 49	0.489435136250533	0.955814781560597	24	25	3914	4278	1.0249893761466
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	 69	0.35533414693411	0.857886601000656	35	34	3903	4269	1.06150771744651
R-HSA-977068	Termination of O-glycan biosynthesis	 17	0.999739138400515	1	2	15	3936	4288	0.246198428584232
R-HSA-977225	Amyloid fiber formation	 51	0.987329007277777	1	17	34	3921	4269	0.697562214321991
R-HSA-977347	Serine biosynthesis	  7	0.73561681688831	1	3	4	3935	4299	0.896865704128274
R-HSA-977441	GABA A receptor activation	 10	0.137803517982411	0.566564079971367	7	3	3931	4300	1.46488065007618
R-HSA-977443	GABA receptor activation	 45	0.38219712419891	0.913621132145993	23	22	3915	4281	1.06959539529372
R-HSA-977444	GABA B receptor activation	 34	0.600261168089032	1	16	18	3922	4285	0.984793714336928
R-HSA-977606	Regulation of Complement cascade	 39	0.999995897316695	1	6	33	3932	4270	0.321951791225534
R-HSA-982772	Growth hormone receptor signaling	 21	0.418494363546959	0.918433256168249	11	10	3927	4293	1.09616919393456
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	 22	0.804645864345466	1	9	13	3929	4290	0.856099081213352
R-HSA-983189	Kinesins	 42	0.865751211703737	1	17	25	3921	4278	0.847039831676703
R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	 47	0.960462974719849	1	17	30	3921	4273	0.756929211285564
R-HSA-991365	Activation of GABAB receptors	 34	0.600261168089032	1	16	18	3922	4285	0.984793714336928
R-HSA-997269	Inhibition of adenylate cyclase pathway	 13	0.983292732593995	1	3	10	3935	4293	0.482927686838301
R-HSA-997272	Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits	 21	0.140467860660899	0.566564079971367	13	8	3925	4295	1.29547268374084
